DB00381Mesalazine may decrease the antihypertensive activities of Amlodipine.
DB00191The risk or severity of hypertension can be increased when Phentermine is combined with Mesalazine.
DB00211The risk or severity of hypertension can be increased when Midodrine is combined with Mesalazine.
DB00216The risk or severity of hypertension can be increased when Eletriptan is combined with Mesalazine.
DB00221The risk or severity of hypertension can be increased when Isoetharine is combined with Mesalazine.
DB00246The risk or severity of hypertension can be increased when Mesalazine is combined with Ziprasidone.
DB00247The risk or severity of hypertension can be increased when Mesalazine is combined with Methysergide.
DB00248The risk or severity of hypertension can be increased when Mesalazine is combined with Cabergoline.
DB00315The risk or severity of hypertension can be increased when Mesalazine is combined with Zolmitriptan.
DB00320The risk or severity of hypertension can be increased when Mesalazine is combined with Dihydroergotamine.
DB00344The risk or severity of hypertension can be increased when Mesalazine is combined with Protriptyline.
DB00353The risk or severity of hypertension can be increased when Mesalazine is combined with Methylergometrine.
DB00368The risk or severity of hypertension can be increased when Mesalazine is combined with Norepinephrine.
DB00370The risk or severity of hypertension can be increased when Mesalazine is combined with Mirtazapine.
DB00388The risk or severity of hypertension can be increased when Mesalazine is combined with Phenylephrine.
DB00397The risk or severity of hypertension can be increased when Mesalazine is combined with Phenylpropanolamine.
DB00420The risk or severity of hypertension can be increased when Mesalazine is combined with Promazine.
DB00450The risk or severity of hypertension can be increased when Mesalazine is combined with Droperidol.
DB00540The risk or severity of hypertension can be increased when Mesalazine is combined with Nortriptyline.
DB00543The risk or severity of hypertension can be increased when Mesalazine is combined with Amoxapine.
DB00561The risk or severity of hypertension can be increased when Mesalazine is combined with Doxapram.
DB00572The risk or severity of hypertension can be increased when Mesalazine is combined with Atropine.
DB00589The risk or severity of hypertension can be increased when Mesalazine is combined with Lisuride.
DB00601The risk or severity of hypertension can be increased when Mesalazine is combined with Linezolid.
DB00610The risk or severity of hypertension can be increased when Mesalazine is combined with Metaraminol.
DB00614The risk or severity of hypertension can be increased when Mesalazine is combined with Furazolidone.
DB00668The risk or severity of hypertension can be increased when Mesalazine is combined with Epinephrine.
DB00679The risk or severity of hypertension can be increased when Mesalazine is combined with Thioridazine.
DB00696The risk or severity of hypertension can be increased when Mesalazine is combined with Ergotamine.
DB00699The risk or severity of hypertension can be increased when Mesalazine is combined with Nicergoline.
DB00708The risk or severity of hypertension can be increased when Mesalazine is combined with Sufentanil.
DB00723The risk or severity of hypertension can be increased when Mesalazine is combined with Methoxamine.
DB00726The risk or severity of hypertension can be increased when Mesalazine is combined with Trimipramine.
DB00734The risk or severity of hypertension can be increased when Mesalazine is combined with Risperidone.
DB00752The risk or severity of hypertension can be increased when Mesalazine is combined with Tranylcypromine.
DB00753The risk or severity of hypertension can be increased when Mesalazine is combined with Isoflurane.
DB00777The risk or severity of hypertension can be increased when Mesalazine is combined with Propiomazine.
DB00802The risk or severity of hypertension can be increased when Mesalazine is combined with Alfentanil.
DB00805The risk or severity of hypertension can be increased when Mesalazine is combined with Minaprine.
DB00816The risk or severity of hypertension can be increased when Mesalazine is combined with Orciprenaline.
DB00818The risk or severity of hypertension can be increased when Mesalazine is combined with Propofol.
DB00830The risk or severity of hypertension can be increased when Mesalazine is combined with Phenmetrazine.
DB00831The risk or severity of hypertension can be increased when Mesalazine is combined with Trifluoperazine.
DB00852The risk or severity of hypertension can be increased when Mesalazine is combined with Pseudoephedrine.
DB00865The risk or severity of hypertension can be increased when Mesalazine is combined with Benzphetamine.
DB00867The risk or severity of hypertension can be increased when Mesalazine is combined with Ritodrine.
DB00875The risk or severity of hypertension can be increased when Mesalazine is combined with Flupentixol.
DB00899The risk or severity of hypertension can be increased when Mesalazine is combined with Remifentanil.
DB00901The risk or severity of hypertension can be increased when Mesalazine is combined with Bitolterol.
DB00935The risk or severity of hypertension can be increased when Mesalazine is combined with Oxymetazoline.
DB00937The risk or severity of hypertension can be increased when Mesalazine is combined with Diethylpropion.
DB00938The risk or severity of hypertension can be increased when Mesalazine is combined with Salmeterol.
DB00952The risk or severity of hypertension can be increased when Mesalazine is combined with Naratriptan.
DB00983The risk or severity of hypertension can be increased when Mesalazine is combined with Formoterol.
DB00998The risk or severity of hypertension can be increased when Mesalazine is combined with Frovatriptan.
DB01028The risk or severity of hypertension can be increased when Mesalazine is combined with Methoxyflurane.
DB01037The risk or severity of hypertension can be increased when Mesalazine is combined with Selegiline.
DB01049The risk or severity of hypertension can be increased when Mesalazine is combined with Ergoloid mesylate.
DB01064The risk or severity of hypertension can be increased when Mesalazine is combined with Isoprenaline.
DB01102The risk or severity of hypertension can be increased when Mesalazine is combined with Arbutamine.
DB01126The risk or severity of hypertension can be increased when Mesalazine is combined with Dutasteride.
DB01159The risk or severity of hypertension can be increased when Mesalazine is combined with Halothane.
DB01171The risk or severity of hypertension can be increased when Mesalazine is combined with Moclobemide.
DB01186The risk or severity of hypertension can be increased when Mesalazine is combined with Pergolide.
DB01189The risk or severity of hypertension can be increased when Mesalazine is combined with Desflurane.
DB01216The risk or severity of hypertension can be increased when Mesalazine is combined with Finasteride.
DB01238The risk or severity of hypertension can be increased when Mesalazine is combined with Aripiprazole.
DB01247The risk or severity of hypertension can be increased when Mesalazine is combined with Isocarboxazid.
DB01253The risk or severity of hypertension can be increased when Mesalazine is combined with Ergometrine.
DB01255The risk or severity of hypertension can be increased when Mesalazine is combined with Lisdexamfetamine.
DB01288The risk or severity of hypertension can be increased when Mesalazine is combined with Fenoterol.
DB01291The risk or severity of hypertension can be increased when Mesalazine is combined with Pirbuterol.
DB01363The risk or severity of hypertension can be increased when Mesalazine is combined with Ephedra sinica root.
DB01364The risk or severity of hypertension can be increased when Mesalazine is combined with Ephedrine.
DB01365The risk or severity of hypertension can be increased when Mesalazine is combined with Mephentermine.
DB01366The risk or severity of hypertension can be increased when Mesalazine is combined with Procaterol.
DB01392The risk or severity of hypertension can be increased when Mesalazine is combined with Yohimbine.
DB01403The risk or severity of hypertension can be increased when Mesalazine is combined with Methotrimeprazine.
DB01407The risk or severity of hypertension can be increased when Mesalazine is combined with Clenbuterol.
DB01408The risk or severity of hypertension can be increased when Mesalazine is combined with Bambuterol.
DB01442The risk or severity of hypertension can be increased when Mesalazine is combined with MMDA.
DB01454The risk or severity of hypertension can be increased when Mesalazine is combined with Midomafetamine.
DB01467The risk or severity of hypertension can be increased when Mesalazine is combined with 2,5-Dimethoxy-4-ethylamphetamine.
DB01472The risk or severity of hypertension can be increased when Mesalazine is combined with 4-Methoxyamphetamine.
DB01484The risk or severity of hypertension can be increased when Mesalazine is combined with 4-Bromo-2,5-dimethoxyamphetamine.
DB01509The risk or severity of hypertension can be increased when Mesalazine is combined with Tenamfetamine.
DB01556The risk or severity of hypertension can be increased when Mesalazine is combined with Chlorphentermine.
DB01576The risk or severity of hypertension can be increased when Mesalazine is combined with Dextroamphetamine.
DB01579The risk or severity of hypertension can be increased when Mesalazine is combined with Phendimetrazine.
DB01591The risk or severity of hypertension can be increased when Mesalazine is combined with Solifenacin.
DB01608The risk or severity of hypertension can be increased when Mesalazine is combined with Periciazine.
DB01614The risk or severity of hypertension can be increased when Mesalazine is combined with Acepromazine.
DB01622The risk or severity of hypertension can be increased when Mesalazine is combined with Thioproperazine.
DB01624The risk or severity of hypertension can be increased when Mesalazine is combined with Zuclopenthixol.
DB02032The risk or severity of hypertension can be increased when Mesalazine is combined with Epicaptopril.
DB04017The risk or severity of hypertension can be increased when Mesalazine is combined with Clorgiline.
DB04581The risk or severity of hypertension can be increased when Mesalazine is combined with 1-benzylimidazole.
DB04818The risk or severity of hypertension can be increased when Mesalazine is combined with Iproniazid.
DB04820The risk or severity of hypertension can be increased when Mesalazine is combined with Nialamide.
DB04829The risk or severity of hypertension can be increased when Mesalazine is combined with Lysergic acid diethylamide.
DB04836The risk or severity of hypertension can be increased when Mesalazine is combined with Amineptine.
DB04855The risk or severity of hypertension can be increased when Mesalazine is combined with Dronedarone.
DB04908The risk or severity of hypertension can be increased when Mesalazine is combined with Flibanserin.
DB04946The risk or severity of hypertension can be increased when Mesalazine is combined with Iloperidone.
DB05039The risk or severity of hypertension can be increased when Mesalazine is combined with Indacaterol.
DB05271The risk or severity of hypertension can be increased when Mesalazine is combined with Rotigotine.
DB05395The risk or severity of hypertension can be increased when Mesalazine is combined with Amibegron.
DB05562The risk or severity of hypertension can be increased when Mesalazine is combined with Naluzotan.
DB06016The risk or severity of hypertension can be increased when Mesalazine is combined with Cariprazine.
DB06148The risk or severity of hypertension can be increased when Mesalazine is combined with Mianserin.
DB06153The risk or severity of hypertension can be increased when Mesalazine is combined with Pizotifen.
DB06190The risk or severity of hypertension can be increased when Mesalazine is combined with Solabegron.
DB06654The risk or severity of hypertension can be increased when Mesalazine is combined with Safinamide.
DB06678The risk or severity of hypertension can be increased when Mesalazine is combined with Esmirtazapine.
DB06684The risk or severity of hypertension can be increased when Mesalazine is combined with Vilazodone.
DB06690The risk or severity of hypertension can be increased when Mesalazine is combined with Nitrous oxide.
DB06701The risk or severity of hypertension can be increased when Mesalazine is combined with Dexmethylphenidate.
DB06706The risk or severity of hypertension can be increased when Mesalazine is combined with Isometheptene.
DB06707The risk or severity of hypertension can be increased when Mesalazine is combined with Levonordefrin.
DB06711The risk or severity of hypertension can be increased when Mesalazine is combined with Naphazoline.
DB06764The risk or severity of hypertension can be increased when Mesalazine is combined with Tetryzoline.
DB08810The risk or severity of hypertension can be increased when Mesalazine is combined with Cinitapride.
DB08815The risk or severity of hypertension can be increased when Mesalazine is combined with Lurasidone.
DB08841The risk or severity of hypertension can be increased when Mesalazine is combined with Tyramine.
DB08925The risk or severity of hypertension can be increased when Mesalazine is combined with Adrafinil.
DB08941The risk or severity of hypertension can be increased when Mesalazine is combined with Isoxsuprine.
DB08954The risk or severity of hypertension can be increased when Mesalazine is combined with Ifenprodil.
DB08957The risk or severity of hypertension can be increased when Mesalazine is combined with Hexoprenaline.
DB08985The risk or severity of hypertension can be increased when Mesalazine is combined with Etilefrine.
DB09016The risk or severity of hypertension can be increased when Mesalazine is combined with Butriptyline.
DB09061The risk or severity of hypertension can be increased when Mesalazine is combined with Cannabidiol.
DB09080The risk or severity of hypertension can be increased when Mesalazine is combined with Olodaterol.
DB09128The risk or severity of hypertension can be increased when Mesalazine is combined with Brexpiprazole.
DB09167The risk or severity of hypertension can be increased when Mesalazine is combined with Dosulepin.
DB09202The risk or severity of hypertension can be increased when Mesalazine is combined with Cirazoline.
DB09203The risk or severity of hypertension can be increased when Mesalazine is combined with Synephrine.
DB09243The risk or severity of hypertension can be increased when Mesalazine is combined with Hydracarbazine.
DB09246The risk or severity of hypertension can be increased when Mesalazine is combined with Benmoxin.
DB09248The risk or severity of hypertension can be increased when Mesalazine is combined with Mebanazine.
DB09249The risk or severity of hypertension can be increased when Mesalazine is combined with Octamoxin.
DB09250The risk or severity of hypertension can be increased when Mesalazine is combined with Pheniprazine.
DB09251The risk or severity of hypertension can be increased when Mesalazine is combined with Phenoxypropazine.
DB09252The risk or severity of hypertension can be increased when Mesalazine is combined with Pivhydrazine.
DB09253The risk or severity of hypertension can be increased when Mesalazine is combined with Safrazine.
DB09254The risk or severity of hypertension can be increased when Mesalazine is combined with Caroxazone.
DB09273The risk or severity of hypertension can be increased when Mesalazine is combined with Doxofylline.
DB09289The risk or severity of hypertension can be increased when Mesalazine is combined with Tianeptine.
DB09307The risk or severity of hypertension can be increased when Mesalazine is combined with Oxaprotiline.
DB09480The risk or severity of hypertension can be increased when Mesalazine is combined with Iofetamine I-123.
DB11124The risk or severity of hypertension can be increased when Mesalazine is combined with Racepinephrine.
DB11273The risk or severity of hypertension can be increased when Mesalazine is combined with Dihydroergocornine.
DB11373The risk or severity of hypertension can be increased when Mesalazine is combined with Amitraz.
DB11428The risk or severity of hypertension can be increased when Mesalazine is combined with Medetomidine.
DB11477The risk or severity of hypertension can be increased when Mesalazine is combined with Xylazine.
DB11481The risk or severity of hypertension can be increased when Mesalazine is combined with Atipamezole.
DB11541The risk or severity of hypertension can be increased when Mesalazine is combined with Ractopamine.
DB11543The risk or severity of hypertension can be increased when Mesalazine is combined with Romifidine.
DB11556The risk or severity of hypertension can be increased when Mesalazine is combined with Detomidine.
DB11755The risk or severity of hypertension can be increased when Mesalazine is combined with Tetrahydrocannabivarin.
DB11871The risk or severity of hypertension can be increased when Mesalazine is combined with PF-00610355.
DB12080The risk or severity of hypertension can be increased when Mesalazine is combined with Ritobegron.
DB12100The risk or severity of hypertension can be increased when Mesalazine is combined with Abediterol.
DB12248The risk or severity of hypertension can be increased when Mesalazine is combined with Tulobuterol.
DB12313The risk or severity of hypertension can be increased when Mesalazine is combined with Dopexamine.
DB12361The risk or severity of hypertension can be increased when Mesalazine is combined with Piclozotan.
DB12371The risk or severity of hypertension can be increased when Mesalazine is combined with Siponimod.
DB12551The risk or severity of hypertension can be increased when Mesalazine is combined with Idazoxan.
DB12779The risk or severity of hypertension can be increased when Mesalazine is combined with Higenamine.
DB12846The risk or severity of hypertension can be increased when Mesalazine is combined with Reproterol.
DB12927The risk or severity of hypertension can be increased when Mesalazine is combined with Theodrenaline.
DB12930The risk or severity of hypertension can be increased when Mesalazine is combined with Opipramol.
DB13064The risk or severity of hypertension can be increased when Mesalazine is combined with Tramazoline.
DB13108The risk or severity of hypertension can be increased when Mesalazine is combined with Mephedrone.
DB13114The risk or severity of hypertension can be increased when Mesalazine is combined with Amitriptylinoxide.
DB13225The risk or severity of hypertension can be increased when Mesalazine is combined with Dibenzepin.
DB13246The risk or severity of hypertension can be increased when Mesalazine is combined with Quinupramine.
DB13251The risk or severity of hypertension can be increased when Mesalazine is combined with Octopamine.
DB13323The risk or severity of hypertension can be increased when Mesalazine is combined with Trichloroethylene.
DB13341The risk or severity of hypertension can be increased when Mesalazine is combined with Fenozolone.
DB13345The risk or severity of hypertension can be increased when Mesalazine is combined with Dihydroergocristine.
DB13378The risk or severity of hypertension can be increased when Mesalazine is combined with Norfenefrine.
DB13384The risk or severity of hypertension can be increased when Mesalazine is combined with Melitracen.
DB13385The risk or severity of hypertension can be increased when Mesalazine is combined with Dihydroergocryptine.
DB13398The risk or severity of hypertension can be increased when Mesalazine is combined with Oxyfedrine.
DB13399The risk or severity of hypertension can be increased when Mesalazine is combined with Terguride.
DB13411The risk or severity of hypertension can be increased when Mesalazine is combined with Lofepramine.
DB13453The risk or severity of hypertension can be increased when Mesalazine is combined with Xenon.
DB13496The risk or severity of hypertension can be increased when Mesalazine is combined with Iprindole.
DB13520The risk or severity of hypertension can be increased when Mesalazine is combined with Metergoline.
DB13559The risk or severity of hypertension can be increased when Mesalazine is combined with Rimiterol.
DB13598The risk or severity of hypertension can be increased when Mesalazine is combined with Diethyl ether.
DB13624The risk or severity of hypertension can be increased when Mesalazine is combined with Methoxyphenamine.
DB13692The risk or severity of hypertension can be increased when Mesalazine is combined with Tretoquinol.
DB13703The risk or severity of hypertension can be increased when Mesalazine is combined with Gepefrine.
DB13777The risk or severity of hypertension can be increased when Mesalazine is combined with Prenalterol.
DB13781The risk or severity of hypertension can be increased when Mesalazine is combined with Xamoterol.
DB13782The risk or severity of hypertension can be increased when Mesalazine is combined with Imipramine oxide.
DB13852The risk or severity of hypertension can be increased when Mesalazine is combined with Mefenorex.
DB13875The risk or severity of hypertension can be increased when Mesalazine is combined with Harmaline.
DB13917The risk or severity of hypertension can be increased when Mesalazine is combined with Deoxyepinephrine.
DB13940The risk or severity of hypertension can be increased when Mesalazine is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
DB14010The risk or severity of hypertension can be increased when Mesalazine is combined with 5-methoxy-N,N-dimethyltryptamine.
DB14185The risk or severity of hypertension can be increased when Mesalazine is combined with Aripiprazole lauroxil.
DB06694The risk or severity of hypertension can be increased when Mesalazine is combined with Xylometazoline.
DB15685The risk or severity of hypertension can be increased when Mesalazine is combined with Selpercatinib.
DB15965The risk or severity of hypertension can be increased when Mesalazine is combined with Naxitamab.
DB06767The serum concentration of Mesalazine can be increased when it is combined with Ammonium chloride.
DB01381Ginkgo biloba may increase the anticoagulant activities of Mesalazine.
DB06813The serum concentration of Pralatrexate can be increased when it is combined with Mesalazine.
DB09026The risk or severity of renal failure and hypertension can be increased when Mesalazine is combined with Aliskiren.
DB01609The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Mesalazine is combined with Deferasirox.
DB00035The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Mesalazine is combined with Desmopressin.
DB00390Mesalazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
DB13401Mesalazine may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
DB13691Mesalazine may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
DB01395The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Drospirenone.
DB00502The therapeutic efficacy of Haloperidol can be increased when used in combination with Mesalazine.
DB01275Mesalazine may decrease the antihypertensive activities of Hydralazine.
DB14507Mesalazine may decrease the excretion rate of Lithium citrate which could result in a higher serum level.
DB14509Mesalazine may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
DB14506Mesalazine may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
DB00563The serum concentration of Methotrexate can be increased when it is combined with Mesalazine.
DB00642Mesalazine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
DB01032Probenecid may decrease the excretion rate of Mesalazine which could result in a higher serum level.
DB00374The risk or severity of bleeding can be increased when Treprostinil is combined with Mesalazine.
DB00512Mesalazine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
DB00529The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Foscarnet.
DB00742The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Mesalazine.
DB00300Mesalazine may increase the nephrotoxic activities of Tenofovir disoproxil.
DB09299Mesalazine may increase the nephrotoxic activities of Tenofovir alafenamide.
DB14126Mesalazine may increase the nephrotoxic activities of Tenofovir.
DB00630The risk or severity of adverse effects can be increased when Mesalazine is combined with Alendronic acid.
DB00501Cimetidine can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00585Nizatidine can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00863Ranitidine can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00927Famotidine can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00940Methantheline can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB01377Magnesium oxide can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB01390Sodium bicarbonate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB06723Aluminum hydroxide can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB06724Calcium carbonate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB08805Metiamide can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB08806Roxatidine acetate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB08938Magaldrate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB09104Magnesium hydroxide can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB09281Magnesium trisilicate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB09481Magnesium carbonate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB12770Lafutidine can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB12884Lavoltidine can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13209Bismuth subnitrate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13249Magnesium silicate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13280Aluminium acetoacetate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13322Hydrotalcite can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13486Magnesium peroxide can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13595Almasilate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13626Aluminium glycinate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13650Aloglutamol can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13760Niperotidine can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13829Calcium silicate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB14517Aluminium phosphate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00213Mesalazine can cause a decrease in the absorption of Pantoprazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB01129Mesalazine can cause a decrease in the absorption of Rabeprazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00338Omeprazole can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00448Lansoprazole can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00736Esomeprazole can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB05351Dexlansoprazole can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13762Dexrabeprazole can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB15246Salvianolic acid A can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB14048Sodium zirconium cyclosilicate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00334The therapeutic efficacy of Mesalazine can be decreased when used in combination with Olanzapine.
DB01069The therapeutic efficacy of Mesalazine can be decreased when used in combination with Promethazine.
DB01142The therapeutic efficacy of Mesalazine can be decreased when used in combination with Doxepin.
DB06216The therapeutic efficacy of Mesalazine can be decreased when used in combination with Asenapine.
DB00751The therapeutic efficacy of Mesalazine can be decreased when used in combination with Epinastine.
DB00001The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Lepirudin.
DB00006The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Bivalirudin.
DB00009The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Alteplase.
DB00013The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Urokinase.
DB00015The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Reteplase.
DB00029The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Anistreplase.
DB00031The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Tenecteplase.
DB00054The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Abciximab.
DB00055The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Drotrecogin alfa.
DB00086The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Streptokinase.
DB00266The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Dicoumarol.
DB00278The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Argatroban.
DB00407The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Ardeparin.
DB00498The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Phenindione.
DB00569The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Fondaparinux.
DB00682The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Warfarin.
DB00686The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Pentosan polysulfate.
DB00946The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Phenprocoumon.
DB00975The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Dipyridamole.
DB01088The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Iloprost.
DB01109The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Heparin.
DB01225The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Enoxaparin.
DB01240The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Epoprostenol.
DB01418The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Acenocoumarol.
DB03410The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with 4-hydroxycoumarin.
DB04665The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Coumarin.
DB04898The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Ximelagatran.
DB04925The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Desmoteplase.
DB04932The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Defibrotide.
DB05099The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Ancrod.
DB05229The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Beraprost.
DB05254The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Fibrinolysin.
DB06209The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Prasugrel.
DB06228The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Rivaroxaban.
DB06271The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Sulodexide.
DB06294The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Semuloparin.
DB06406The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Idraparinux.
DB06441The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Cangrelor.
DB06543The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Astaxanthin.
DB06605The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Apixaban.
DB06635The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Otamixaban.
DB06679The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Amediplase.
DB06695The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Dabigatran etexilate.
DB06754The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Danaparoid.
DB06779The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Dalteparin.
DB06822The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Tinzaparin.
DB07767The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Ferulic acid.
DB08496The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with (R)-warfarin.
DB08794The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Ethyl biscoumacetate.
DB08813The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Nadroparin.
DB08814The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Triflusal.
DB08816The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Ticagrelor.
DB08994The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Ditazole.
DB09030The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Vorapaxar.
DB09075The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Edoxaban.
DB09125The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Potassium citrate.
DB09154The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Sodium citrate.
DB09255The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Dextran.
DB09258The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Bemiparin.
DB09260The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Parnaparin.
DB11095The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Desirudin.
DB11154The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Zinc citrate.
DB11166The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Antithrombin Alfa.
DB11312The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Protein C.
DB11598The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Antithrombin III human.
DB11984The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Letaxaban.
DB12289The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Darexaban.
DB12598The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Nafamostat.
DB12726The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Monteplase.
DB12831The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Gabexate.
DB13136The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Fluindione.
DB13149The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Protein S human.
DB13199The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Brinase.
DB13275The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Clorindione.
DB13347The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Diphenadione.
DB13451The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Tioclomarol.
DB13616The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Melagatran.
DB13646The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Saruplase.
DB14055The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with (S)-Warfarin.
DB14094The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Tocopherylquinone.
DB14598The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Edetate calcium disodium anhydrous.
DB14726The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Dabigatran.
DB09259The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Reviparin.
DB13124The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Troxerutin.
DB00974The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Edetic acid.
DB00177The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Mesalazine.
DB00275The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Mesalazine.
DB00678The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Mesalazine.
DB00796The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan cilexetil is combined with Mesalazine.
DB00876The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Mesalazine.
DB00966The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Mesalazine.
DB01029The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Mesalazine.
DB01342The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Mesalazine.
DB01347The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Mesalazine.
DB01349The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Mesalazine.
DB06763The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Mesalazine.
DB08822The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Mesalazine.
DB09279The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Mesalazine.
DB13919The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Mesalazine.
DB00178The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Ramipril.
DB00492The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Fosinopril.
DB00519The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Trandolapril.
DB00542The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Benazepril.
DB00584The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Enalapril.
DB00691The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Moexipril.
DB00722The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Lisinopril.
DB00790The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Perindopril.
DB00881The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Quinapril.
DB00886The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Omapatrilat.
DB01180The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Rescinnamine.
DB01197The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Captopril.
DB01340The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Cilazapril.
DB01348The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Spirapril.
DB08836The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Temocapril.
DB09477The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Enalaprilat.
DB11783The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Imidapril.
DB13166The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Zofenopril.
DB13312The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Delapril.
DB14125The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Benazeprilat.
DB14207The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Fosinoprilat.
DB14208The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Ramiprilat.
DB14209The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Trandolaprilat.
DB14210The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Moexiprilat.
DB14213The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Perindoprilat.
DB14217The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Quinaprilat.
DB14231The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Quinoline Yellow WS.
DB15565The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Cilazaprilat.
DB00187Mesalazine may decrease the antihypertensive activities of Esmolol.
DB00195Mesalazine may decrease the antihypertensive activities of Betaxolol.
DB00264Mesalazine may decrease the antihypertensive activities of Metoprolol.
DB00335Mesalazine may decrease the antihypertensive activities of Atenolol.
DB00373Mesalazine may decrease the antihypertensive activities of Timolol.
DB00489Mesalazine may decrease the antihypertensive activities of Sotalol.
DB00571Mesalazine may decrease the antihypertensive activities of Propranolol.
DB00598Mesalazine may decrease the antihypertensive activities of Labetalol.
DB00612Mesalazine may decrease the antihypertensive activities of Bisoprolol.
DB00866Mesalazine may decrease the antihypertensive activities of Alprenolol.
DB00960Mesalazine may decrease the antihypertensive activities of Pindolol.
DB01136Mesalazine may decrease the antihypertensive activities of Carvedilol.
DB01182Mesalazine may decrease the antihypertensive activities of Propafenone.
DB01193Mesalazine may decrease the antihypertensive activities of Acebutolol.
DB01203Mesalazine may decrease the antihypertensive activities of Nadolol.
DB01295Mesalazine may decrease the antihypertensive activities of Bevantolol.
DB01297Mesalazine may decrease the antihypertensive activities of Practolol.
DB01359Mesalazine may decrease the antihypertensive activities of Penbutolol.
DB01580Mesalazine may decrease the antihypertensive activities of Oxprenolol.
DB03322Mesalazine may decrease the antihypertensive activities of Dexpropranolol.
DB04846Mesalazine may decrease the antihypertensive activities of Celiprolol.
DB04861Mesalazine may decrease the antihypertensive activities of Nebivolol.
DB06726Mesalazine may decrease the antihypertensive activities of Bufuralol.
DB08807Mesalazine may decrease the antihypertensive activities of Bopindolol.
DB08808Mesalazine may decrease the antihypertensive activities of Bupranolol.
DB08952Mesalazine may decrease the antihypertensive activities of Indenolol.
DB09204Mesalazine may decrease the antihypertensive activities of Arotinolol.
DB09351Mesalazine may decrease the antihypertensive activities of Levobetaxolol.
DB11770Mesalazine may decrease the antihypertensive activities of Talinolol.
DB11785Mesalazine may decrease the antihypertensive activities of Anisodamine.
DB12752Mesalazine may decrease the antihypertensive activities of Bucindolol.
DB13443Mesalazine may decrease the antihypertensive activities of Esatenolol.
DB13508Mesalazine may decrease the antihypertensive activities of Cloranolol.
DB13530Mesalazine may decrease the antihypertensive activities of Mepindolol.
DB13757Mesalazine may decrease the antihypertensive activities of Epanolol.
DB13775Mesalazine may decrease the antihypertensive activities of Tertatolol.
DB12212Mesalazine may decrease the antihypertensive activities of Landiolol.
DB00214The therapeutic efficacy of Torasemide can be decreased when used in combination with Mesalazine.
DB00887The therapeutic efficacy of Bumetanide can be decreased when used in combination with Mesalazine.
DB00903The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Mesalazine.
DB02925The therapeutic efficacy of Piretanide can be decreased when used in combination with Mesalazine.
DB08961The therapeutic efficacy of Azosemide can be decreased when used in combination with Mesalazine.
DB00218Mesalazine may increase the neuroexcitatory activities of Moxifloxacin.
DB00365Mesalazine may increase the neuroexcitatory activities of Grepafloxacin.
DB00467Mesalazine may increase the neuroexcitatory activities of Enoxacin.
DB00487Mesalazine may increase the neuroexcitatory activities of Pefloxacin.
DB00685Mesalazine may increase the neuroexcitatory activities of Trovafloxacin.
DB00779Mesalazine may increase the neuroexcitatory activities of Nalidixic acid.
DB00817Mesalazine may increase the neuroexcitatory activities of Rosoxacin.
DB00827Mesalazine may increase the neuroexcitatory activities of Cinoxacin.
DB00978Mesalazine may increase the neuroexcitatory activities of Lomefloxacin.
DB01044Mesalazine may increase the neuroexcitatory activities of Gatifloxacin.
DB01059Mesalazine may increase the neuroexcitatory activities of Norfloxacin.
DB01155Mesalazine may increase the neuroexcitatory activities of Gemifloxacin.
DB01165Mesalazine may increase the neuroexcitatory activities of Ofloxacin.
DB01208Mesalazine may increase the neuroexcitatory activities of Sparfloxacin.
DB01405Mesalazine may increase the neuroexcitatory activities of Temafloxacin.
DB04576Mesalazine may increase the neuroexcitatory activities of Fleroxacin.
DB05488Mesalazine may increase the neuroexcitatory activities of Technetium Tc-99m ciprofloxacin.
DB06160Mesalazine may increase the neuroexcitatory activities of Garenoxacin.
DB06600Mesalazine may increase the neuroexcitatory activities of Nemonoxacin.
DB08972Mesalazine may increase the neuroexcitatory activities of Flumequine.
DB11404Mesalazine may increase the neuroexcitatory activities of Enrofloxacin.
DB11443Mesalazine may increase the neuroexcitatory activities of Orbifloxacin.
DB11491Mesalazine may increase the neuroexcitatory activities of Sarafloxacin.
DB11511Mesalazine may increase the neuroexcitatory activities of Difloxacin.
DB11774Mesalazine may increase the neuroexcitatory activities of Pazufloxacin.
DB11892Mesalazine may increase the neuroexcitatory activities of Prulifloxacin.
DB13261Mesalazine may increase the neuroexcitatory activities of Sitafloxacin.
DB13627Mesalazine may increase the neuroexcitatory activities of Oxolinic acid.
DB13772Mesalazine may increase the neuroexcitatory activities of Rufloxacin.
DB13823Mesalazine may increase the neuroexcitatory activities of Pipemidic acid.
DB00232The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Mesalazine.
DB00310The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Mesalazine.
DB00436The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Mesalazine.
DB00524The therapeutic efficacy of Metolazone can be decreased when used in combination with Mesalazine.
DB00562The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Mesalazine.
DB00774The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Mesalazine.
DB00808The therapeutic efficacy of Indapamide can be decreased when used in combination with Mesalazine.
DB00880The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Mesalazine.
DB00999The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Mesalazine.
DB01021The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Mesalazine.
DB01324The therapeutic efficacy of Polythiazide can be decreased when used in combination with Mesalazine.
DB01325The therapeutic efficacy of Quinethazone can be decreased when used in combination with Mesalazine.
DB13532The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Mesalazine.
DB13989The therapeutic efficacy of Epitizide can be decreased when used in combination with Mesalazine.
DB01009The risk or severity of bleeding and gastrointestinal bleeding can be increased when Mesalazine is combined with Ketoprofen.
DB09214The risk or severity of bleeding and gastrointestinal bleeding can be increased when Mesalazine is combined with Dexketoprofen.
DB00511The serum concentration of Acetyldigitoxin can be decreased when it is combined with Mesalazine.
DB01078The serum concentration of Deslanoside can be decreased when it is combined with Mesalazine.
DB01092The serum concentration of Ouabain can be decreased when it is combined with Mesalazine.
DB01396The serum concentration of Digitoxin can be decreased when it is combined with Mesalazine.
DB12843The serum concentration of Oleandrin can be decreased when it is combined with Mesalazine.
DB13240The serum concentration of Cymarin can be decreased when it is combined with Mesalazine.
DB13307The serum concentration of Proscillaridin can be decreased when it is combined with Mesalazine.
DB13467The serum concentration of Lanatoside C can be decreased when it is combined with Mesalazine.
DB13537The serum concentration of Gitoformate can be decreased when it is combined with Mesalazine.
DB13756The serum concentration of Peruvoside can be decreased when it is combined with Mesalazine.
DB00282The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Pamidronic acid.
DB00399The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Zoledronic acid.
DB00710The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Ibandronate.
DB00720The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Clodronic acid.
DB00884The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Risedronic acid.
DB01077The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Etidronic acid.
DB01133The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Tiludronic acid.
DB06255The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Incadronic acid.
DB00287The therapeutic efficacy of Travoprost can be decreased when used in combination with Mesalazine.
DB00654The therapeutic efficacy of Latanoprost can be decreased when used in combination with Mesalazine.
DB00905The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Mesalazine.
DB01160The therapeutic efficacy of Dinoprost tromethamine can be decreased when used in combination with Mesalazine.
DB02056The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Mesalazine.
DB02304The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Mesalazine.
DB03866The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Mesalazine.
DB06826The therapeutic efficacy of Unoprostone can be decreased when used in combination with Mesalazine.
DB08819The therapeutic efficacy of Tafluprost can be decreased when used in combination with Mesalazine.
DB09211The therapeutic efficacy of Limaprost can be decreased when used in combination with Mesalazine.
DB11411The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Mesalazine.
DB11425The therapeutic efficacy of Luprostiol can be decreased when used in combination with Mesalazine.
DB11454The therapeutic efficacy of Prostalene can be decreased when used in combination with Mesalazine.
DB11507The therapeutic efficacy of Cloprostenol can be decreased when used in combination with Mesalazine.
DB11519The therapeutic efficacy of Fluprostenol can be decreased when used in combination with Mesalazine.
DB11660The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Mesalazine.
DB13824The therapeutic efficacy of Enprostil can be decreased when used in combination with Mesalazine.
DB04865The risk or severity of bleeding can be increased when Mesalazine is combined with Omacetaxine mepesuccinate.
DB00864The risk or severity of renal failure can be increased when Mesalazine is combined with Tacrolimus.
DB00352The metabolism of Tioguanine can be decreased when combined with Mesalazine.
DB01033The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.
DB00375Colestipol can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00658Sevelamer can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00930Colesevelam can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB01432Cholestyramine can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00384The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Triamterene.
DB00421The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Spironolactone.
DB00594The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Amiloride.
DB00700The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Eplerenone.
DB09015The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Canrenoic acid.
DB12221The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Canrenone.
DB00229The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Mesalazine.
DB00267The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefmenoxime.
DB00274The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefmetazole.
DB00430The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefpiramide.
DB00447The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Loracarbef.
DB00456The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefalotin.
DB00493The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefotaxime.
DB00626The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Bacitracin.
DB00681The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Amphotericin B.
DB00689The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cephaloglycin.
DB00718The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Adefovir dipivoxil.
DB00923The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Ceforanide.
DB01066The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefditoren.
DB01072The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Atazanavir.
DB01111The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Colistimethate.
DB01112The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefuroxime.
DB01139The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefapirin.
DB01150The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefprozil.
DB01326The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefamandole.
DB01327The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefazolin.
DB01328The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefonicid.
DB01329The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefoperazone.
DB01331The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefoxitin.
DB01332The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Ceftizoxime.
DB01413The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefepime.
DB01414The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefacetrile.
DB01416The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefpodoxime.
DB01601The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Lopinavir.
DB02247The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Hydrolyzed Cephalothin.
DB03450The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cephalothin Group.
DB04570The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Latamoxef.
DB04918The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Ceftobiprole.
DB06590The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Ceftaroline fosamil.
DB09008The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefaloridine.
DB09062The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefminox.
DB11935The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Flomoxef.
DB13266The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefatrizine.
DB13461The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefcapene.
DB13470The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefodizime.
DB13499The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefsulodin.
DB13504The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefetamet.
DB13638The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefbuperazone.
DB13667The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefozopran.
DB13682The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefpirome.
DB13778The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefazedone.
DB13821The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Ceftezole.
DB13868The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Adefovir.
DB14713The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Inotersen.
DB01438The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Phenazopyridine.
DB15066The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Givosiran.
DB00452The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Framycetin.
DB01421The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Paromomycin.
DB04263The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Geneticin.
DB04626The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Apramycin.
DB04808The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Neamine.
DB08437The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Puromycin.
DB11512The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Dihydrostreptomycin.
DB11520The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Hygromycin B.
DB01356The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Lithium cation.
DB00215The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Mesalazine.
DB00472The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Mesalazine.
DB00656The risk or severity of gastrointestinal bleeding can be increased when Trazodone is combined with Mesalazine.
DB01175The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Mesalazine.
DB04832The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Mesalazine.
DB04884The risk or severity of gastrointestinal bleeding can be increased when Dapoxetine is combined with Mesalazine.
DB06731The risk or severity of gastrointestinal bleeding can be increased when Seproxetine is combined with Mesalazine.
DB08953The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Mesalazine.
DB12693The risk or severity of gastrointestinal bleeding can be increased when Ritanserin is combined with Mesalazine.
DB13233The risk or severity of gastrointestinal bleeding can be increased when Alaproclate is combined with Mesalazine.
DB00476The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Mesalazine.
DB01105The risk or severity of gastrointestinal bleeding can be increased when Sibutramine is combined with Mesalazine.
DB04896The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Mesalazine.
DB06700The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Mesalazine.
DB08918The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Mesalazine.
DB00176The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Fluvoxamine.
DB01149The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Nefazodone.
DB00715The risk or severity of gastrointestinal bleeding can be increased when Paroxetine is combined with Mesalazine.
DB00834Mesalazine may increase the hypoglycemic activities of Mifepristone.
DB00030Mesalazine may increase the hypoglycemic activities of Insulin human.
DB00046Mesalazine may increase the hypoglycemic activities of Insulin lispro.
DB00047Mesalazine may increase the hypoglycemic activities of Insulin glargine.
DB00071Mesalazine may increase the hypoglycemic activities of Insulin pork.
DB00197Mesalazine may increase the hypoglycemic activities of Troglitazone.
DB00222Mesalazine may increase the hypoglycemic activities of Glimepiride.
DB00263Mesalazine may increase the hypoglycemic activities of Sulfisoxazole.
DB00280Mesalazine may increase the hypoglycemic activities of Disopyramide.
DB00284Mesalazine may increase the hypoglycemic activities of Acarbose.
DB00331Mesalazine may increase the hypoglycemic activities of Metformin.
DB00359Mesalazine may increase the hypoglycemic activities of Sulfadiazine.
DB00412Mesalazine may increase the hypoglycemic activities of Rosiglitazone.
DB00414Mesalazine may increase the hypoglycemic activities of Acetohexamide.
DB00468Mesalazine may increase the hypoglycemic activities of Quinine.
DB00491Mesalazine may increase the hypoglycemic activities of Miglitol.
DB00672Mesalazine may increase the hypoglycemic activities of Chlorpropamide.
DB00731Mesalazine may increase the hypoglycemic activities of Nateglinide.
DB00738Mesalazine may increase the hypoglycemic activities of Pentamidine.
DB00839Mesalazine may increase the hypoglycemic activities of Tolazamide.
DB00912Mesalazine may increase the hypoglycemic activities of Repaglinide.
DB00914Mesalazine may increase the hypoglycemic activities of Phenformin.
DB01015Mesalazine may increase the hypoglycemic activities of Sulfamethoxazole.
DB01016Mesalazine may increase the hypoglycemic activities of Glyburide.
DB01067Mesalazine may increase the hypoglycemic activities of Glipizide.
DB01120Mesalazine may increase the hypoglycemic activities of Gliclazide.
DB01124Mesalazine may increase the hypoglycemic activities of Tolbutamide.
DB01132Mesalazine may increase the hypoglycemic activities of Pioglitazone.
DB01200Mesalazine may increase the hypoglycemic activities of Bromocriptine.
DB01251Mesalazine may increase the hypoglycemic activities of Gliquidone.
DB01252Mesalazine may increase the hypoglycemic activities of Mitiglinide.
DB01261Mesalazine may increase the hypoglycemic activities of Sitagliptin.
DB01268Mesalazine may increase the hypoglycemic activities of Sunitinib.
DB01276Mesalazine may increase the hypoglycemic activities of Exenatide.
DB01277Mesalazine may increase the hypoglycemic activities of Mecasermin.
DB01278Mesalazine may increase the hypoglycemic activities of Pramlintide.
DB01289Mesalazine may increase the hypoglycemic activities of Glisoxepide.
DB01306Mesalazine may increase the hypoglycemic activities of Insulin aspart.
DB01307Mesalazine may increase the hypoglycemic activities of Insulin detemir.
DB01309Mesalazine may increase the hypoglycemic activities of Insulin glulisine.
DB01382Mesalazine may increase the hypoglycemic activities of Glymidine.
DB01700Mesalazine may increase the hypoglycemic activities of AICA ribonucleotide.
DB04830Mesalazine may increase the hypoglycemic activities of Buformin.
DB04876Mesalazine may increase the hypoglycemic activities of Vildagliptin.
DB04878Mesalazine may increase the hypoglycemic activities of Voglibose.
DB05115Mesalazine may increase the hypoglycemic activities of NN344.
DB05819Mesalazine may increase the hypoglycemic activities of NBI-6024.
DB06011Mesalazine may increase the hypoglycemic activities of AMG-222.
DB06127Mesalazine may increase the hypoglycemic activities of Bisegliptin.
DB06203Mesalazine may increase the hypoglycemic activities of Alogliptin.
DB06292Mesalazine may increase the hypoglycemic activities of Dapagliflozin.
DB06335Mesalazine may increase the hypoglycemic activities of Saxagliptin.
DB06655Mesalazine may increase the hypoglycemic activities of Liraglutide.
DB08382Mesalazine may increase the hypoglycemic activities of Gosogliptin.
DB08882Mesalazine may increase the hypoglycemic activities of Linagliptin.
DB08907Mesalazine may increase the hypoglycemic activities of Canagliflozin.
DB08962Mesalazine may increase the hypoglycemic activities of Glibornuride.
DB09022Mesalazine may increase the hypoglycemic activities of Benfluorex.
DB09038Mesalazine may increase the hypoglycemic activities of Empagliflozin.
DB09043Mesalazine may increase the hypoglycemic activities of Albiglutide.
DB09045Mesalazine may increase the hypoglycemic activities of Dulaglutide.
DB09198Mesalazine may increase the hypoglycemic activities of Lobeglitazone.
DB09199Mesalazine may increase the hypoglycemic activities of Netoglitazone.
DB09200Mesalazine may increase the hypoglycemic activities of Rivoglitazone.
DB09201Mesalazine may increase the hypoglycemic activities of Ciglitazone.
DB09265Mesalazine may increase the hypoglycemic activities of Lixisenatide.
DB09456Mesalazine may increase the hypoglycemic activities of Insulin beef.
DB09564Mesalazine may increase the hypoglycemic activities of Insulin degludec.
DB11567Mesalazine may increase the hypoglycemic activities of Insulin peglispro.
DB11568Mesalazine may increase the hypoglycemic activities of Insulin tregopil.
DB11698Mesalazine may increase the hypoglycemic activities of Ipragliflozin.
DB11723Mesalazine may increase the hypoglycemic activities of Dutogliptin.
DB11780Mesalazine may increase the hypoglycemic activities of Allicin.
DB11824Mesalazine may increase the hypoglycemic activities of Tofogliflozin.
DB11827Mesalazine may increase the hypoglycemic activities of Ertugliflozin.
DB11898Mesalazine may increase the hypoglycemic activities of 2,4-thiazolidinedione.
DB11950Mesalazine may increase the hypoglycemic activities of Teneligliptin.
DB11992Mesalazine may increase the hypoglycemic activities of Omarigliptin.
DB12268Mesalazine may increase the hypoglycemic activities of Carmegliptin.
DB12412Mesalazine may increase the hypoglycemic activities of Gemigliptin.
DB12417Mesalazine may increase the hypoglycemic activities of Anagliptin.
DB12625Mesalazine may increase the hypoglycemic activities of Evogliptin.
DB12713Mesalazine may increase the hypoglycemic activities of Sotagliflozin.
DB12781Mesalazine may increase the hypoglycemic activities of Balaglitazone.
DB12935Mesalazine may increase the hypoglycemic activities of Remogliflozin etabonate.
DB13406Mesalazine may increase the hypoglycemic activities of Carbutamide.
DB13446Mesalazine may increase the hypoglycemic activities of Guar gum.
DB13675Mesalazine may increase the hypoglycemic activities of Metahexamide.
DB13928Mesalazine may increase the hypoglycemic activities of Semaglutide.
DB14027Mesalazine may increase the hypoglycemic activities of Taspoglutide.
DB14035Mesalazine may increase the hypoglycemic activities of Englitazone.
DB15171Mesalazine may increase the hypoglycemic activities of Tirzepatide.
DB15217Mesalazine may increase the hypoglycemic activities of Gastric inhibitory polypeptide.
DB00311The risk or severity of adverse effects can be increased when Mesalazine is combined with Ethoxzolamide.
DB00703The risk or severity of adverse effects can be increased when Mesalazine is combined with Methazolamide.
DB00819The risk or severity of adverse effects can be increased when Mesalazine is combined with Acetazolamide.
DB00909The risk or severity of adverse effects can be increased when Mesalazine is combined with Zonisamide.
DB01144The risk or severity of adverse effects can be increased when Mesalazine is combined with Diclofenamide.
DB00313The serum concentration of Valproic acid can be increased when it is combined with Mesalazine.
DB00159The therapeutic efficacy of Mesalazine can be decreased when used in combination with Icosapent.
DB00233The therapeutic efficacy of Aminosalicylic acid can be decreased when used in combination with Mesalazine.
DB00795The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Mesalazine.
DB00861The therapeutic efficacy of Diflunisal can be decreased when used in combination with Mesalazine.
DB00945The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Mesalazine.
DB01014The therapeutic efficacy of Balsalazide can be decreased when used in combination with Mesalazine.
DB01250The therapeutic efficacy of Olsalazine can be decreased when used in combination with Mesalazine.
DB01294The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Mesalazine.
DB06251The therapeutic efficacy of Dersalazine can be decreased when used in combination with Mesalazine.
DB06807The therapeutic efficacy of Phenyl aminosalicylate can be decreased when used in combination with Mesalazine.
DB09543The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Mesalazine.
DB11079The therapeutic efficacy of Trolamine salicylate can be decreased when used in combination with Mesalazine.
DB12445The therapeutic efficacy of Nitroaspirin can be decreased when used in combination with Mesalazine.
DB13509The therapeutic efficacy of Aloxiprin can be decreased when used in combination with Mesalazine.
DB13538The therapeutic efficacy of Guacetisal can be decreased when used in combination with Mesalazine.
DB13612The therapeutic efficacy of Carbaspirin calcium can be decreased when used in combination with Mesalazine.
DB14006The therapeutic efficacy of Choline salicylate can be decreased when used in combination with Mesalazine.
DB14026The therapeutic efficacy of Thiosalicylic acid can be decreased when used in combination with Mesalazine.
DB00328The therapeutic efficacy of Mesalazine can be decreased when used in combination with Indomethacin.
DB00461The therapeutic efficacy of Mesalazine can be decreased when used in combination with Nabumetone.
DB00469The therapeutic efficacy of Mesalazine can be decreased when used in combination with Tenoxicam.
DB00500The therapeutic efficacy of Mesalazine can be decreased when used in combination with Tolmetin.
DB00554The therapeutic efficacy of Mesalazine can be decreased when used in combination with Piroxicam.
DB00573The therapeutic efficacy of Mesalazine can be decreased when used in combination with Fenoprofen.
DB00586The therapeutic efficacy of Mesalazine can be decreased when used in combination with Diclofenac.
DB00605The therapeutic efficacy of Mesalazine can be decreased when used in combination with Sulindac.
DB00712The therapeutic efficacy of Mesalazine can be decreased when used in combination with Flurbiprofen.
DB00749The therapeutic efficacy of Mesalazine can be decreased when used in combination with Etodolac.
DB00784The therapeutic efficacy of Mesalazine can be decreased when used in combination with Mefenamic acid.
DB00788The therapeutic efficacy of Mesalazine can be decreased when used in combination with Naproxen.
DB00812The therapeutic efficacy of Mesalazine can be decreased when used in combination with Phenylbutazone.
DB00814The therapeutic efficacy of Mesalazine can be decreased when used in combination with Meloxicam.
DB00821The therapeutic efficacy of Mesalazine can be decreased when used in combination with Carprofen.
DB00870The therapeutic efficacy of Mesalazine can be decreased when used in combination with Suprofen.
DB00939The therapeutic efficacy of Mesalazine can be decreased when used in combination with Meclofenamic acid.
DB00963The therapeutic efficacy of Mesalazine can be decreased when used in combination with Bromfenac.
DB00991The therapeutic efficacy of Mesalazine can be decreased when used in combination with Oxaprozin.
DB01397The therapeutic efficacy of Mesalazine can be decreased when used in combination with Magnesium salicylate.
DB01399The therapeutic efficacy of Mesalazine can be decreased when used in combination with Salsalate.
DB01401The therapeutic efficacy of Mesalazine can be decreased when used in combination with Choline magnesium trisalicylate.
DB01419The therapeutic efficacy of Mesalazine can be decreased when used in combination with Antrafenine.
DB01435The therapeutic efficacy of Mesalazine can be decreased when used in combination with Antipyrine.
DB01600The therapeutic efficacy of Mesalazine can be decreased when used in combination with Tiaprofenic acid.
DB06725The therapeutic efficacy of Mesalazine can be decreased when used in combination with Lornoxicam.
DB06736The therapeutic efficacy of Mesalazine can be decreased when used in combination with Aceclofenac.
DB06802The therapeutic efficacy of Mesalazine can be decreased when used in combination with Nepafenac.
DB09213The therapeutic efficacy of Mesalazine can be decreased when used in combination with Dexibuprofen.
DB09215The therapeutic efficacy of Mesalazine can be decreased when used in combination with Droxicam.
DB13346The therapeutic efficacy of Mesalazine can be decreased when used in combination with Bufexamac.
DB00343The risk or severity of bleeding can be increased when Diltiazem is combined with Mesalazine.
DB00661The risk or severity of bleeding can be increased when Verapamil is combined with Mesalazine.
DB00285Venlafaxine may increase the antiplatelet activities of Mesalazine.
DB00180The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Flunisolide.
DB00443The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Betamethasone.
DB00620The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Triamcinolone.
DB00635The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Prednisone.
DB00687The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Fludrocortisone.
DB00741The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Hydrocortisone.
DB00860The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Prednisolone.
DB00959The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Methylprednisolone.
DB01108The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Trilostane.
DB01222The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Budesonide.
DB01234The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Dexamethasone.
DB01285The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Corticotropin.
DB01380The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Cortisone acetate.
DB01384The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Paramethasone.
DB04630The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Aldosterone.
DB09378The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Fluprednisolone.
DB09383The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Meprednisone.
DB11529The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Melengestrol.
DB11921The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Deflazacort.
DB13003The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Cortivazol.
DB13208The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Prednylidene.
DB13843The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Cloprednol.
DB14681The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Cortisone.
DB00394The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Mesalazine.
DB00588The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Mesalazine.
DB00591The risk or severity of gastrointestinal irritation can be increased when Fluocinolone acetonide is combined with Mesalazine.
DB01410The risk or severity of gastrointestinal irritation can be increased when Ciclesonide is combined with Mesalazine.
DB08906The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Mesalazine.
DB08970The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Mesalazine.
DB09091The risk or severity of gastrointestinal irritation can be increased when Tixocortol is combined with Mesalazine.
DB11487The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Mesalazine.
DB13223The risk or severity of gastrointestinal irritation can be increased when Fluocortin is combined with Mesalazine.
DB13491The risk or severity of gastrointestinal irritation can be increased when Fluperolone is combined with Mesalazine.
DB13856The risk or severity of gastrointestinal irritation can be increased when Fluclorolone is combined with Mesalazine.
DB13867The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Mesalazine.
DB14512The risk or severity of gastrointestinal irritation can be increased when Mometasone furoate is combined with Mesalazine.
DB14539The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Mesalazine.
DB14541The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Mesalazine.
DB14545The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Mesalazine.
DB14631The risk or severity of gastrointestinal irritation can be increased when Prednisolone phosphate is combined with Mesalazine.
DB14633The risk or severity of gastrointestinal irritation can be increased when Prednisolone hemisuccinate is combined with Mesalazine.
DB14644The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone hemisuccinate is combined with Mesalazine.
DB14646The risk or severity of gastrointestinal irritation can be increased when Prednisone acetate is combined with Mesalazine.
DB14652The risk or severity of gastrointestinal irritation can be increased when Clocortolone acetate is combined with Mesalazine.
DB14659The risk or severity of gastrointestinal irritation can be increased when Melengestrol acetate is combined with Mesalazine.
DB14669The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Mesalazine.
DB01013The risk or severity of gastrointestinal irritation can be increased when Clobetasol propionate is combined with Mesalazine.
DB01047The risk or severity of gastrointestinal irritation can be increased when Fluocinonide is combined with Mesalazine.
DB14540The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Mesalazine.
DB00547The risk or severity of gastrointestinal irritation can be increased when Desoximetasone is combined with Mesalazine.
DB00764The risk or severity of gastrointestinal irritation can be increased when Mometasone is combined with Mesalazine.
DB08971The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Mesalazine.
DB11750The risk or severity of gastrointestinal irritation can be increased when Clobetasol is combined with Mesalazine.
DB15566The risk or severity of gastrointestinal irritation can be increased when Prednisolone acetate is combined with Mesalazine.
DB00324The risk or severity of gastrointestinal irritation can be increased when Fluorometholone is combined with Mesalazine.
DB09095The risk or severity of gastrointestinal irritation can be increased when Difluocortolone is combined with Mesalazine.
DB00202The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Mesalazine.
DB01026The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Ketoconazole.
DB01074The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Perhexiline.
DB01167The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Itraconazole.
DB01219The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Dantrolene.
DB02968The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Penicillin G Acyl-Serine.
DB06212The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Tolvaptan.
DB12097The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Mannitol busulfan.
DB00825The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Levomenthol.
DB00347The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Trimethadione.
DB00568The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Cinnarizine.
DB00593The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Ethosuximide.
DB00653The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Magnesium sulfate.
DB00836The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Loperamide.
DB01118The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Amiodarone.
DB04825The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Prenylamine.
DB04838The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Cyclandelate.
DB04841The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Flunarizine.
DB04842The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Fluspirilene.
DB05246The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Methsuximide.
DB05885The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Seletracetam.
DB06152The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Nylidrin.
DB06446The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Dotarizine.
DB08838The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Agmatine.
DB08980The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Fendiline.
DB08992The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Eperisone.
DB09090The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Pinaverium.
DB09227The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Barnidipine.
DB09229The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Aranidipine.
DB09230The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Azelnidipine.
DB09231The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Benidipine.
DB09232The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Cilnidipine.
DB09234The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Darodipine.
DB09240The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Niludipine.
DB11960The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Carboxyamidotriazole.
DB12131The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Vinpocetine.
DB12923The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Gallopamil.
DB13488The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Bencyclane.
DB13500The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Otilonium.
DB13725The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Terodiline.
DB13766The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Lidoflazine.
DB13791The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Penfluridol.
DB13835The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Caroverine.
DB13950The risk or severity of hyperkalemia can be increased when Mesalazine is combined with WIN 55212-2.
DB13961The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Fish oil.
DB14063The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Dexverapamil.
DB14064The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Emopamil.
DB14065The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Lomerizine.
DB14066The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Tetrandrine.
DB09261The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Certoparin.
DB10076The risk or severity of adverse effects can be increased when Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen is combined with Mesalazine.
DB10342The risk or severity of adverse effects can be increased when Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen is combined with Mesalazine.
DB10600The risk or severity of adverse effects can be increased when Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) is combined with Mesalazine.
DB10794The risk or severity of adverse effects can be increased when Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) is combined with Mesalazine.
DB10990The risk or severity of adverse effects can be increased when Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen is combined with Mesalazine.
DB11038The risk or severity of adverse effects can be increased when Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) is combined with Mesalazine.
DB11040The risk or severity of adverse effects can be increased when Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) is combined with Mesalazine.
DB11041The risk or severity of adverse effects can be increased when Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) is combined with Mesalazine.
DB11044The risk or severity of adverse effects can be increased when Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) is combined with Mesalazine.
DB14384The risk or severity of adverse effects can be increased when Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) is combined with Mesalazine.
DB14385The risk or severity of adverse effects can be increased when Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) is combined with Mesalazine.
DB14394The risk or severity of adverse effects can be increased when Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen is combined with Mesalazine.
DB14445The risk or severity of adverse effects can be increased when Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) is combined with Mesalazine.
DB14449The risk or severity of adverse effects can be increased when Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen is combined with Mesalazine.
DB14619The risk or severity of adverse effects can be increased when Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) is combined with Mesalazine.
DB14620The risk or severity of adverse effects can be increased when Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) is combined with Mesalazine.
DB09413The serum concentration of Mesalazine can be increased when it is combined with Monopotassium phosphate.
DB10318The risk or severity of adverse effects can be increased when Mesalazine is combined with Varicella Zoster Vaccine (Live/attenuated).
DB09449The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Mesalazine.
DB12364The risk or severity of bleeding can be increased when Betrixaban is combined with Mesalazine.
DB01023The therapeutic efficacy of Felodipine can be decreased when used in combination with Mesalazine.
DB00206The therapeutic efficacy of Reserpine can be decreased when used in combination with Mesalazine.
DB00212The therapeutic efficacy of Remikiren can be decreased when used in combination with Mesalazine.
DB00217The therapeutic efficacy of Bethanidine can be decreased when used in combination with Mesalazine.
DB00226The therapeutic efficacy of Guanadrel can be decreased when used in combination with Mesalazine.
DB00325The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Mesalazine.
DB00350The therapeutic efficacy of Minoxidil can be decreased when used in combination with Mesalazine.
DB00457The therapeutic efficacy of Prazosin can be decreased when used in combination with Mesalazine.
DB00559The therapeutic efficacy of Bosentan can be decreased when used in combination with Mesalazine.
DB00575The therapeutic efficacy of Clonidine can be decreased when used in combination with Mesalazine.
DB00590The therapeutic efficacy of Doxazosin can be decreased when used in combination with Mesalazine.
DB00606The therapeutic efficacy of Cyclothiazide can be decreased when used in combination with Mesalazine.
DB00616The therapeutic efficacy of Candoxatril can be decreased when used in combination with Mesalazine.
DB00629The therapeutic efficacy of Guanabenz can be decreased when used in combination with Mesalazine.
DB00657The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Mesalazine.
DB00692The therapeutic efficacy of Phentolamine can be decreased when used in combination with Mesalazine.
DB00727The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Mesalazine.
DB00765The therapeutic efficacy of Metyrosine can be decreased when used in combination with Mesalazine.
DB00785The therapeutic efficacy of Cryptenamine can be decreased when used in combination with Mesalazine.
DB00797The therapeutic efficacy of Tolazoline can be decreased when used in combination with Mesalazine.
DB00800The therapeutic efficacy of Fenoldopam can be decreased when used in combination with Mesalazine.
DB00925The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Mesalazine.
DB00968The therapeutic efficacy of Methyldopa can be decreased when used in combination with Mesalazine.
DB01018The therapeutic efficacy of Guanfacine can be decreased when used in combination with Mesalazine.
DB01089The therapeutic efficacy of Deserpidine can be decreased when used in combination with Mesalazine.
DB01090The therapeutic efficacy of Pentolinium can be decreased when used in combination with Mesalazine.
DB01116The therapeutic efficacy of Trimethaphan can be decreased when used in combination with Mesalazine.
DB01119The therapeutic efficacy of Diazoxide can be decreased when used in combination with Mesalazine.
DB01158The therapeutic efficacy of Bretylium can be decreased when used in combination with Mesalazine.
DB01162The therapeutic efficacy of Terazosin can be decreased when used in combination with Mesalazine.
DB01170The therapeutic efficacy of Guanethidine can be decreased when used in combination with Mesalazine.
DB01626The therapeutic efficacy of Pargyline can be decreased when used in combination with Mesalazine.
DB04831The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Mesalazine.
DB04840The therapeutic efficacy of Debrisoquine can be decreased when used in combination with Mesalazine.
DB04948The therapeutic efficacy of Lofexidine can be decreased when used in combination with Mesalazine.
DB06268The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Mesalazine.
DB06403The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Mesalazine.
DB06445The therapeutic efficacy of Diethylnorspermine can be decreased when used in combination with Mesalazine.
DB06762The therapeutic efficacy of Pinacidil can be decreased when used in combination with Mesalazine.
DB08931The therapeutic efficacy of Riociguat can be decreased when used in combination with Mesalazine.
DB08932The therapeutic efficacy of Macitentan can be decreased when used in combination with Mesalazine.
DB08950The therapeutic efficacy of Indoramin can be decreased when used in combination with Mesalazine.
DB08960The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Mesalazine.
DB09206The therapeutic efficacy of Trimazosin can be decreased when used in combination with Mesalazine.
DB09220The therapeutic efficacy of Nicorandil can be decreased when used in combination with Mesalazine.
DB09242The therapeutic efficacy of Moxonidine can be decreased when used in combination with Mesalazine.
DB09363The therapeutic efficacy of Rauwolfia serpentina root can be decreased when used in combination with Mesalazine.
DB11362The therapeutic efficacy of Selexipag can be decreased when used in combination with Mesalazine.
DB11720The therapeutic efficacy of Angiotensin 1-7 can be decreased when used in combination with Mesalazine.
DB11738The therapeutic efficacy of Rilmenidine can be decreased when used in combination with Mesalazine.
DB12054The therapeutic efficacy of BQ-123 can be decreased when used in combination with Mesalazine.
DB12661The therapeutic efficacy of Urapidil can be decreased when used in combination with Mesalazine.
DB12766The therapeutic efficacy of Cicletanine can be decreased when used in combination with Mesalazine.
DB12945The therapeutic efficacy of Dihydralazine can be decreased when used in combination with Mesalazine.
DB13211The therapeutic efficacy of Guanoxan can be decreased when used in combination with Mesalazine.
DB13374The therapeutic efficacy of Vincamine can be decreased when used in combination with Mesalazine.
DB13410The therapeutic efficacy of Guanoxabenz can be decreased when used in combination with Mesalazine.
DB13429The therapeutic efficacy of Tolonidine can be decreased when used in combination with Mesalazine.
DB13435The therapeutic efficacy of Endralazine can be decreased when used in combination with Mesalazine.
DB13452The therapeutic efficacy of Cadralazine can be decreased when used in combination with Mesalazine.
DB13575The therapeutic efficacy of Bietaserpine can be decreased when used in combination with Mesalazine.
DB13604The therapeutic efficacy of Guanazodine can be decreased when used in combination with Mesalazine.
DB13631The therapeutic efficacy of Methoserpidine can be decreased when used in combination with Mesalazine.
DB13779The therapeutic efficacy of Guanoclor can be decreased when used in combination with Mesalazine.
DB13801The therapeutic efficacy of Muzolimine can be decreased when used in combination with Mesalazine.
DB13803The therapeutic efficacy of Xipamide can be decreased when used in combination with Mesalazine.
DB00393The therapeutic efficacy of Nimodipine can be decreased when used in combination with Mesalazine.
DB00528The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Mesalazine.
DB00622The therapeutic efficacy of Nicardipine can be decreased when used in combination with Mesalazine.
DB01054The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Mesalazine.
DB01244The therapeutic efficacy of Bepridil can be decreased when used in combination with Mesalazine.
DB01388The therapeutic efficacy of Mibefradil can be decreased when used in combination with Mesalazine.
DB06712The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Mesalazine.
DB09235The therapeutic efficacy of Efonidipine can be decreased when used in combination with Mesalazine.
DB09236The therapeutic efficacy of Lacidipine can be decreased when used in combination with Mesalazine.
DB09238The therapeutic efficacy of Manidipine can be decreased when used in combination with Mesalazine.
DB09239The therapeutic efficacy of Niguldipine can be decreased when used in combination with Mesalazine.
DB12093The therapeutic efficacy of Tetrahydropalmatine can be decreased when used in combination with Mesalazine.
DB14068The therapeutic efficacy of Dexniguldipine can be decreased when used in combination with Mesalazine.
DB09237The therapeutic efficacy of Levamlodipine can be decreased when used in combination with Mesalazine.
DB00091The risk or severity of renal failure and hypertension can be increased when Mesalazine is combined with Cyclosporine.
DB13615The therapeutic efficacy of Mifamurtide can be decreased when used in combination with Mesalazine.
DB11051The risk or severity of adverse effects can be increased when Mesalazine is combined with Azficel-T.
DB11642The risk or severity of adverse effects can be increased when Mesalazine is combined with Pitolisant.
DB00482The risk or severity of adverse effects can be increased when Celecoxib is combined with Mesalazine.
DB00533The risk or severity of adverse effects can be increased when Rofecoxib is combined with Mesalazine.
DB00580The risk or severity of adverse effects can be increased when Valdecoxib is combined with Mesalazine.
DB00936The risk or severity of adverse effects can be increased when Salicylic acid is combined with Mesalazine.
DB01050The risk or severity of adverse effects can be increased when Ibuprofen is combined with Mesalazine.
DB01283The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Mesalazine.
DB01628The risk or severity of adverse effects can be increased when Etoricoxib is combined with Mesalazine.
DB03585The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Mesalazine.
DB04552The risk or severity of adverse effects can be increased when Niflumic acid is combined with Mesalazine.
DB04812The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Mesalazine.
DB04817The risk or severity of adverse effects can be increased when Metamizole is combined with Mesalazine.
DB04828The risk or severity of adverse effects can be increased when Zomepirac is combined with Mesalazine.
DB06737The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Mesalazine.
DB07402The risk or severity of adverse effects can be increased when Azapropazone is combined with Mesalazine.
DB07477The risk or severity of adverse effects can be increased when Felbinac is combined with Mesalazine.
DB08439The risk or severity of adverse effects can be increased when Parecoxib is combined with Mesalazine.
DB08797The risk or severity of adverse effects can be increased when Salicylamide is combined with Mesalazine.
DB08940The risk or severity of adverse effects can be increased when Kebuzone is combined with Mesalazine.
DB08942The risk or severity of adverse effects can be increased when Isoxicam is combined with Mesalazine.
DB08951The risk or severity of adverse effects can be increased when Indoprofen is combined with Mesalazine.
DB08955The risk or severity of adverse effects can be increased when Ibuproxam is combined with Mesalazine.
DB08976The risk or severity of adverse effects can be increased when Floctafenine is combined with Mesalazine.
DB08981The risk or severity of adverse effects can be increased when Fenbufen is combined with Mesalazine.
DB08984The risk or severity of adverse effects can be increased when Etofenamate is combined with Mesalazine.
DB08991The risk or severity of adverse effects can be increased when Epirizole is combined with Mesalazine.
DB09212The risk or severity of adverse effects can be increased when Loxoprofen is combined with Mesalazine.
DB09216The risk or severity of adverse effects can be increased when Tolfenamic acid is combined with Mesalazine.
DB09218The risk or severity of adverse effects can be increased when Clonixin is combined with Mesalazine.
DB11466The risk or severity of adverse effects can be increased when Tepoxalin is combined with Mesalazine.
DB11518The risk or severity of adverse effects can be increased when Flunixin is combined with Mesalazine.
DB13001The risk or severity of adverse effects can be increased when Tinoridine is combined with Mesalazine.
DB13167The risk or severity of adverse effects can be increased when Alclofenac is combined with Mesalazine.
DB13217The risk or severity of adverse effects can be increased when Fentiazac is combined with Mesalazine.
DB13232The risk or severity of adverse effects can be increased when Suxibuzone is combined with Mesalazine.
DB13286The risk or severity of adverse effects can be increased when Bumadizone is combined with Mesalazine.
DB13314The risk or severity of adverse effects can be increased when Alminoprofen is combined with Mesalazine.
DB13364The risk or severity of adverse effects can be increased when Feprazone is combined with Mesalazine.
DB13371The risk or severity of adverse effects can be increased when Difenpiramide is combined with Mesalazine.
DB13407The risk or severity of adverse effects can be increased when Nifenazone is combined with Mesalazine.
DB13432The risk or severity of adverse effects can be increased when Lonazolac is combined with Mesalazine.
DB13481The risk or severity of adverse effects can be increased when Tenidap is combined with Mesalazine.
DB13501The risk or severity of adverse effects can be increased when Bendazac is combined with Mesalazine.
DB13514The risk or severity of adverse effects can be increased when Pranoprofen is combined with Mesalazine.
DB13524The risk or severity of adverse effects can be increased when Propyphenazone is combined with Mesalazine.
DB13527The risk or severity of adverse effects can be increased when Proglumetacin is combined with Mesalazine.
DB13544The risk or severity of adverse effects can be increased when Ethenzamide is combined with Mesalazine.
DB13629The risk or severity of adverse effects can be increased when Mofebutazone is combined with Mesalazine.
DB13649The risk or severity of adverse effects can be increased when Proquazone is combined with Mesalazine.
DB13657The risk or severity of adverse effects can be increased when Benorilate is combined with Mesalazine.
DB13722The risk or severity of adverse effects can be increased when Pirprofen is combined with Mesalazine.
DB13783The risk or severity of adverse effects can be increased when Acemetacin is combined with Mesalazine.
DB13860The risk or severity of adverse effects can be increased when Imidazole salicylate is combined with Mesalazine.
DB09084The risk or severity of adverse effects can be increased when Benzydamine is combined with Mesalazine.
DB05095The risk or severity of adverse effects can be increased when Cimicoxib is combined with Mesalazine.
DB11455The risk or severity of adverse effects can be increased when Robenacoxib is combined with Mesalazine.
DB01424The risk or severity of adverse effects can be increased when Aminophenazone is combined with Mesalazine.
DB14059The risk or severity of adverse effects can be increased when Mesalazine is combined with SC-236.
DB14060The risk or severity of adverse effects can be increased when Mesalazine is combined with NS-398.
DB09217The risk or severity of adverse effects can be increased when Mesalazine is combined with Firocoxib.
DB09285The risk or severity of adverse effects can be increased when Mesalazine is combined with Morniflumate.
DB09295The risk or severity of adverse effects can be increased when Mesalazine is combined with Talniflumate.
DB02224The risk or severity of adverse effects can be increased when Mesalazine is combined with Taxifolin.
DB12480The risk or severity of adverse effects can be increased when Mesalazine is combined with Betulinic Acid.
DB12610The risk or severity of adverse effects can be increased when Mesalazine is combined with Ebselen.
DB14938The risk or severity of adverse effects can be increased when Mesalazine is combined with Flurbiprofen axetil.
DB12399The risk or severity of adverse effects can be increased when Mesalazine is combined with Polmacoxib.
DB04725The risk or severity of adverse effects can be increased when Mesalazine is combined with Licofelone.
DB04743The risk or severity of adverse effects can be increased when Mesalazine is combined with Nimesulide.
DB12545The risk or severity of adverse effects can be increased when Mesalazine is combined with Indobufen.
DB00007Mesalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level.
DB00014Mesalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.
DB00017Mesalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00041Mesalazine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00080Mesalazine may decrease the excretion rate of Daptomycin which could result in a higher serum level.
DB00081Mesalazine may decrease the excretion rate of Tositumomab which could result in a higher serum level.
DB00115Mesalazine may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.
DB00158Mesalazine may decrease the excretion rate of Folic acid which could result in a higher serum level.
DB00165Mesalazine may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
DB00182Mesalazine may decrease the excretion rate of Amphetamine which could result in a higher serum level.
DB00185Mesalazine may decrease the excretion rate of Cevimeline which could result in a higher serum level.
DB00186Mesalazine may decrease the excretion rate of Lorazepam which could result in a higher serum level.
DB00190Mesalazine may decrease the excretion rate of Carbidopa which could result in a higher serum level.
DB00193Mesalazine may decrease the excretion rate of Tramadol which could result in a higher serum level.
DB00196Mesalazine may decrease the excretion rate of Fluconazole which could result in a higher serum level.
DB00198Mesalazine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
DB00200Mesalazine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
DB00225Mesalazine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
DB00230Mesalazine may decrease the excretion rate of Pregabalin which could result in a higher serum level.
DB00231Mesalazine may decrease the excretion rate of Temazepam which could result in a higher serum level.
DB00235Mesalazine may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00237Mesalazine may decrease the excretion rate of Butabarbital which could result in a higher serum level.
DB00243Mesalazine may decrease the excretion rate of Ranolazine which could result in a higher serum level.
DB00245Mesalazine may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00254Mesalazine may decrease the excretion rate of Doxycycline which could result in a higher serum level.
DB00262Mesalazine may decrease the excretion rate of Carmustine which could result in a higher serum level.
DB00271Mesalazine may decrease the excretion rate of Diatrizoate which could result in a higher serum level.
DB00273Mesalazine may decrease the excretion rate of Topiramate which could result in a higher serum level.
DB00279Mesalazine may decrease the excretion rate of Liothyronine which could result in a higher serum level.
DB00286Mesalazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
DB00289Mesalazine may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
DB00290Mesalazine may decrease the excretion rate of Bleomycin which could result in a higher serum level.
DB00292Mesalazine may decrease the excretion rate of Etomidate which could result in a higher serum level.
DB00294Mesalazine may decrease the excretion rate of Etonogestrel which could result in a higher serum level.
DB00296Mesalazine may decrease the excretion rate of Ropivacaine which could result in a higher serum level.
DB00303Mesalazine may decrease the excretion rate of Ertapenem which could result in a higher serum level.
DB00308Mesalazine may decrease the excretion rate of Ibutilide which could result in a higher serum level.
DB00312Mesalazine may decrease the excretion rate of Pentobarbital which could result in a higher serum level.
DB00319Mesalazine may decrease the excretion rate of Piperacillin which could result in a higher serum level.
DB00322Mesalazine may decrease the excretion rate of Floxuridine which could result in a higher serum level.
DB00323Mesalazine may decrease the excretion rate of Tolcapone which could result in a higher serum level.
DB00327Mesalazine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
DB00330Mesalazine may decrease the excretion rate of Ethambutol which could result in a higher serum level.
DB00333Mesalazine may decrease the excretion rate of Methadone which could result in a higher serum level.
DB00339Mesalazine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
DB00341Mesalazine may decrease the excretion rate of Cetirizine which could result in a higher serum level.
DB00349Mesalazine may decrease the excretion rate of Clobazam which could result in a higher serum level.
DB00351Mesalazine may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.
DB00355Mesalazine may decrease the excretion rate of Aztreonam which could result in a higher serum level.
DB00356Mesalazine may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
DB00363Mesalazine may decrease the excretion rate of Clozapine which could result in a higher serum level.
DB00364Mesalazine may decrease the excretion rate of Sucralfate which could result in a higher serum level.
DB00369Mesalazine may decrease the excretion rate of Cidofovir which could result in a higher serum level.
DB00372Mesalazine may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.
DB00377Mesalazine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
DB00380Mesalazine may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
DB00398Mesalazine may decrease the excretion rate of Sorafenib which could result in a higher serum level.
DB00402Mesalazine may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
DB00404Mesalazine may decrease the excretion rate of Alprazolam which could result in a higher serum level.
DB00413Mesalazine may decrease the excretion rate of Pramipexole which could result in a higher serum level.
DB00415Mesalazine may decrease the excretion rate of Ampicillin which could result in a higher serum level.
DB00418Mesalazine may decrease the excretion rate of Secobarbital which could result in a higher serum level.
DB00422Mesalazine may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
DB00432Mesalazine may decrease the excretion rate of Trifluridine which could result in a higher serum level.
DB00435Mesalazine may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.
DB00437Mesalazine may decrease the excretion rate of Allopurinol which could result in a higher serum level.
DB00438Mesalazine may decrease the excretion rate of Ceftazidime which could result in a higher serum level.
DB00440Mesalazine may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
DB00441Mesalazine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
DB00477Mesalazine may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
DB00480Mesalazine may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
DB00490Mesalazine may decrease the excretion rate of Buspirone which could result in a higher serum level.
DB00499Mesalazine may decrease the excretion rate of Flutamide which could result in a higher serum level.
DB00535Mesalazine may decrease the excretion rate of Cefdinir which could result in a higher serum level.
DB00537Mesalazine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
DB00548Mesalazine may decrease the excretion rate of Azelaic acid which could result in a higher serum level.
DB00553Mesalazine may decrease the excretion rate of Methoxsalen which could result in a higher serum level.
DB00558Mesalazine may decrease the excretion rate of Zanamivir which could result in a higher serum level.
DB00567Mesalazine may decrease the excretion rate of Cephalexin which could result in a higher serum level.
DB00577Mesalazine may decrease the excretion rate of Valaciclovir which could result in a higher serum level.
DB00583Mesalazine may decrease the excretion rate of Levocarnitine which could result in a higher serum level.
DB00597Mesalazine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.
DB00603Mesalazine may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.
DB00608Mesalazine may decrease the excretion rate of Chloroquine which could result in a higher serum level.
DB00624Mesalazine may decrease the excretion rate of Testosterone which could result in a higher serum level.
DB00628Mesalazine may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
DB00631Mesalazine may decrease the excretion rate of Clofarabine which could result in a higher serum level.
DB00633Mesalazine may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.
DB00651Mesalazine may decrease the excretion rate of Dyphylline which could result in a higher serum level.
DB00660Mesalazine may decrease the excretion rate of Metaxalone which could result in a higher serum level.
DB00665Mesalazine may decrease the excretion rate of Nilutamide which could result in a higher serum level.
DB00669Mesalazine may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
DB00683Mesalazine may decrease the excretion rate of Midazolam which could result in a higher serum level.
DB00688Mesalazine may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
DB00690Mesalazine may decrease the excretion rate of Flurazepam which could result in a higher serum level.
DB00698Mesalazine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
DB00706Mesalazine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
DB00709Mesalazine may decrease the excretion rate of Lamivudine which could result in a higher serum level.
DB00713Mesalazine may decrease the excretion rate of Oxacillin which could result in a higher serum level.
DB00716Mesalazine may decrease the excretion rate of Nedocromil which could result in a higher serum level.
DB00730Mesalazine may decrease the excretion rate of Thiabendazole which could result in a higher serum level.
DB00733Mesalazine may decrease the excretion rate of Pralidoxime which could result in a higher serum level.
DB00743Mesalazine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.
DB00759Mesalazine may decrease the excretion rate of Tetracycline which could result in a higher serum level.
DB00760Mesalazine may decrease the excretion rate of Meropenem which could result in a higher serum level.
DB00761Mesalazine may decrease the excretion rate of Potassium chloride which could result in a higher serum level.
DB00763Mesalazine may decrease the excretion rate of Methimazole which could result in a higher serum level.
DB00780Mesalazine may decrease the excretion rate of Phenelzine which could result in a higher serum level.
DB00782Mesalazine may decrease the excretion rate of Propantheline which could result in a higher serum level.
DB00783Mesalazine may decrease the excretion rate of Estradiol which could result in a higher serum level.
DB00787Mesalazine may decrease the excretion rate of Acyclovir which could result in a higher serum level.
DB00789Mesalazine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.
DB00804Mesalazine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
DB00811Mesalazine may decrease the excretion rate of Ribavirin which could result in a higher serum level.
DB00820Mesalazine may decrease the excretion rate of Tadalafil which could result in a higher serum level.
DB00828Mesalazine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
DB00829Mesalazine may decrease the excretion rate of Diazepam which could result in a higher serum level.
DB00833Mesalazine may decrease the excretion rate of Cefaclor which could result in a higher serum level.
DB00841Mesalazine may decrease the excretion rate of Dobutamine which could result in a higher serum level.
DB00842Mesalazine may decrease the excretion rate of Oxazepam which could result in a higher serum level.
DB00851Mesalazine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
DB00853Mesalazine may decrease the excretion rate of Temozolomide which could result in a higher serum level.
DB00871Mesalazine may decrease the excretion rate of Terbutaline which could result in a higher serum level.
DB00894Mesalazine may decrease the excretion rate of Testolactone which could result in a higher serum level.
DB00897Mesalazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
DB00900Mesalazine may decrease the excretion rate of Didanosine which could result in a higher serum level.
DB00911Mesalazine may decrease the excretion rate of Tinidazole which could result in a higher serum level.
DB00915Mesalazine may decrease the excretion rate of Amantadine which could result in a higher serum level.
DB00918Mesalazine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
DB00928Mesalazine may decrease the excretion rate of Azacitidine which could result in a higher serum level.
DB00934Mesalazine may decrease the excretion rate of Maprotiline which could result in a higher serum level.
DB00951Mesalazine may decrease the excretion rate of Isoniazid which could result in a higher serum level.
DB00953Mesalazine may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
DB00958Mesalazine may decrease the excretion rate of Carboplatin which could result in a higher serum level.
DB00961Mesalazine may decrease the excretion rate of Mepivacaine which could result in a higher serum level.
DB00962Mesalazine may decrease the excretion rate of Zaleplon which could result in a higher serum level.
DB00980Mesalazine may decrease the excretion rate of Ramelteon which could result in a higher serum level.
DB00988Mesalazine may decrease the excretion rate of Dopamine which could result in a higher serum level.
DB00993Mesalazine may decrease the excretion rate of Azathioprine which could result in a higher serum level.
DB00995Mesalazine may decrease the excretion rate of Auranofin which could result in a higher serum level.
DB01001Mesalazine may decrease the excretion rate of Salbutamol which could result in a higher serum level.
DB01002Mesalazine may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.
DB01004Mesalazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
DB01010Mesalazine may decrease the excretion rate of Edrophonium which could result in a higher serum level.
DB01011Mesalazine may decrease the excretion rate of Metyrapone which could result in a higher serum level.
DB01020Mesalazine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.
DB01022Mesalazine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
DB01024Mesalazine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
DB01030Mesalazine may decrease the excretion rate of Topotecan which could result in a higher serum level.
DB01036Mesalazine may decrease the excretion rate of Tolterodine which could result in a higher serum level.
DB01039Mesalazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
DB01043Mesalazine may decrease the excretion rate of Memantine which could result in a higher serum level.
DB01046Mesalazine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
DB01048Mesalazine may decrease the excretion rate of Abacavir which could result in a higher serum level.
DB01060Mesalazine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
DB01068Mesalazine may decrease the excretion rate of Clonazepam which could result in a higher serum level.
DB01093Mesalazine may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.
DB01099Mesalazine may decrease the excretion rate of Flucytosine which could result in a higher serum level.
DB01101Mesalazine may decrease the excretion rate of Capecitabine which could result in a higher serum level.
DB01135Mesalazine may decrease the excretion rate of Doxacurium which could result in a higher serum level.
DB01137Mesalazine may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
DB01140Mesalazine may decrease the excretion rate of Cefadroxil which could result in a higher serum level.
DB01148Mesalazine may decrease the excretion rate of Flavoxate which could result in a higher serum level.
DB01156Mesalazine may decrease the excretion rate of Bupropion which could result in a higher serum level.
DB01157Mesalazine may decrease the excretion rate of Trimetrexate which could result in a higher serum level.
DB01169Mesalazine may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
DB01181Mesalazine may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
DB01183Mesalazine may decrease the excretion rate of Naloxone which could result in a higher serum level.
DB01205Mesalazine may decrease the excretion rate of Flumazenil which could result in a higher serum level.
DB01212Mesalazine may decrease the excretion rate of Ceftriaxone which could result in a higher serum level.
DB01213Mesalazine may decrease the excretion rate of Fomepizole which could result in a higher serum level.
DB01215Mesalazine may decrease the excretion rate of Estazolam which could result in a higher serum level.
DB01221Mesalazine may decrease the excretion rate of Ketamine which could result in a higher serum level.
DB01224Mesalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.
DB01233Mesalazine may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
DB01241Mesalazine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
DB01249Mesalazine may decrease the excretion rate of Iodixanol which could result in a higher serum level.
DB01267Mesalazine may decrease the excretion rate of Paliperidone which could result in a higher serum level.
DB01273Mesalazine may decrease the excretion rate of Varenicline which could result in a higher serum level.
DB01274Mesalazine may decrease the excretion rate of Arformoterol which could result in a higher serum level.
DB01330Mesalazine may decrease the excretion rate of Cefotetan which could result in a higher serum level.
DB01333Mesalazine may decrease the excretion rate of Cefradine which could result in a higher serum level.
DB01367Mesalazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
DB01394Mesalazine may decrease the excretion rate of Colchicine which could result in a higher serum level.
DB01409Mesalazine may decrease the excretion rate of Tiotropium which could result in a higher serum level.
DB01415Mesalazine may decrease the excretion rate of Ceftibuten which could result in a higher serum level.
DB01420Mesalazine may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.
DB01427Mesalazine may decrease the excretion rate of Amrinone which could result in a higher serum level.
DB01428Mesalazine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.
DB01431Mesalazine may decrease the excretion rate of Allylestrenol which could result in a higher serum level.
DB01550Mesalazine may decrease the excretion rate of Fenproporex which could result in a higher serum level.
DB01558Mesalazine may decrease the excretion rate of Bromazepam which could result in a higher serum level.
DB01563Mesalazine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.
DB01577Mesalazine may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
DB01587Mesalazine may decrease the excretion rate of Ketazolam which could result in a higher serum level.
DB01610Mesalazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
DB01638Mesalazine may decrease the excretion rate of Sorbitol which could result in a higher serum level.
DB01656Mesalazine may decrease the excretion rate of Roflumilast which could result in a higher serum level.
DB01685Mesalazine may decrease the excretion rate of Topiroxostat which could result in a higher serum level.
DB04574Mesalazine may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.
DB04871Mesalazine may decrease the excretion rate of Lorcaserin which could result in a higher serum level.
DB04895Mesalazine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
DB04953Mesalazine may decrease the excretion rate of Ezogabine which could result in a higher serum level.
DB05018Mesalazine may decrease the excretion rate of Migalastat which could result in a higher serum level.
DB05541Mesalazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
DB05676Mesalazine may decrease the excretion rate of Apremilast which could result in a higher serum level.
DB06154Mesalazine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.
DB06186Mesalazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
DB06196Mesalazine may decrease the excretion rate of Icatibant which could result in a higher serum level.
DB06211Mesalazine may decrease the excretion rate of Doripenem which could result in a higher serum level.
DB06230Mesalazine may decrease the excretion rate of Nalmefene which could result in a higher serum level.
DB06262Mesalazine may decrease the excretion rate of Droxidopa which could result in a higher serum level.
DB06282Mesalazine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
DB06402Mesalazine may decrease the excretion rate of Telavancin which could result in a higher serum level.
DB06480Mesalazine may decrease the excretion rate of Prucalopride which could result in a higher serum level.
DB06623Mesalazine may decrease the excretion rate of Flupirtine which could result in a higher serum level.
DB06637Mesalazine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
DB06702Mesalazine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
DB06705Mesalazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.
DB06710Mesalazine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.
DB06782Mesalazine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
DB06796Mesalazine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.
DB06800Mesalazine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
DB06809Mesalazine may decrease the excretion rate of Plerixafor which could result in a higher serum level.
DB06823Mesalazine may decrease the excretion rate of Tiopronin which could result in a higher serum level.
DB06824Mesalazine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.
DB08824Mesalazine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.
DB08826Mesalazine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
DB08840Mesalazine may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.
DB08872Mesalazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
DB08877Mesalazine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
DB08893Mesalazine may decrease the excretion rate of Mirabegron which could result in a higher serum level.
DB08894Mesalazine may decrease the excretion rate of Peginesatide which could result in a higher serum level.
DB08897Mesalazine may decrease the excretion rate of Aclidinium which could result in a higher serum level.
DB08899Mesalazine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
DB08900Mesalazine may decrease the excretion rate of Teduglutide which could result in a higher serum level.
DB08904Mesalazine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
DB08905Mesalazine may decrease the excretion rate of Formestane which could result in a higher serum level.
DB08909Mesalazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.
DB08910Mesalazine may decrease the excretion rate of Pomalidomide which could result in a higher serum level.
DB08911Mesalazine may decrease the excretion rate of Trametinib which could result in a higher serum level.
DB08934Mesalazine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
DB09027Mesalazine may decrease the excretion rate of Ledipasvir which could result in a higher serum level.
DB09050Mesalazine may decrease the excretion rate of Ceftolozane which could result in a higher serum level.
DB09066Mesalazine may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.
DB09068Mesalazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
DB09071Mesalazine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
DB09081Mesalazine may decrease the excretion rate of Idebenone which could result in a higher serum level.
DB09082Mesalazine may decrease the excretion rate of Vilanterol which could result in a higher serum level.
DB09103Mesalazine may decrease the excretion rate of Ancestim which could result in a higher serum level.
DB09106Mesalazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.
DB09111Mesalazine may decrease the excretion rate of Pentastarch which could result in a higher serum level.
DB09118Mesalazine may decrease the excretion rate of Stiripentol which could result in a higher serum level.
DB09121Mesalazine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.
DB09123Mesalazine may decrease the excretion rate of Dienogest which could result in a higher serum level.
DB09129Mesalazine may decrease the excretion rate of Chromic chloride which could result in a higher serum level.
DB09132Mesalazine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.
DB09133Mesalazine may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
DB09134Mesalazine may decrease the excretion rate of Ioversol which could result in a higher serum level.
DB09135Mesalazine may decrease the excretion rate of Ioxilan which could result in a higher serum level.
DB09136Mesalazine may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.
DB09137Mesalazine may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.
DB09139Mesalazine may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.
DB09148Mesalazine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.
DB09149Mesalazine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.
DB09156Mesalazine may decrease the excretion rate of Iopromide which could result in a higher serum level.
DB09163Mesalazine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.
DB09165Mesalazine may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.
DB09185Mesalazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
DB09194Mesalazine may decrease the excretion rate of Etoperidone which could result in a higher serum level.
DB09195Mesalazine may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.
DB09205Mesalazine may decrease the excretion rate of Moxisylyte which could result in a higher serum level.
DB09209Mesalazine may decrease the excretion rate of Pholcodine which could result in a higher serum level.
DB09210Mesalazine may decrease the excretion rate of Piracetam which could result in a higher serum level.
DB09219Mesalazine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.
DB09223Mesalazine may decrease the excretion rate of Blonanserin which could result in a higher serum level.
DB09224Mesalazine may decrease the excretion rate of Melperone which could result in a higher serum level.
DB09241Mesalazine may decrease the excretion rate of Methylene blue which could result in a higher serum level.
DB09244Mesalazine may decrease the excretion rate of Pirlindole which could result in a higher serum level.
DB09245Mesalazine may decrease the excretion rate of Toloxatone which could result in a higher serum level.
DB09256Mesalazine may decrease the excretion rate of Tegafur which could result in a higher serum level.
DB09257Mesalazine may decrease the excretion rate of Gimeracil which could result in a higher serum level.
DB09262Mesalazine may decrease the excretion rate of Imidafenacin which could result in a higher serum level.
DB09264Mesalazine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.
DB09268Mesalazine may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.
DB09276Mesalazine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.
DB09277Mesalazine may decrease the excretion rate of Choline C 11 which could result in a higher serum level.
DB09292Mesalazine may decrease the excretion rate of Sacubitril which could result in a higher serum level.
DB09301Mesalazine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.
DB09317Mesalazine may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.
DB09318Mesalazine may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.
DB09320Mesalazine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
DB09324Mesalazine may decrease the excretion rate of Sulbactam which could result in a higher serum level.
DB09325Mesalazine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.
DB09329Mesalazine may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.
DB09338Mesalazine may decrease the excretion rate of Mersalyl which could result in a higher serum level.
DB09344Mesalazine may decrease the excretion rate of Invert sugar which could result in a higher serum level.
DB09357Mesalazine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
DB09394Mesalazine may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.
DB09395Mesalazine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.
DB09407Mesalazine may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.
DB09418Mesalazine may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.
DB09472Mesalazine may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.
DB09488Mesalazine may decrease the excretion rate of Acrivastine which could result in a higher serum level.
DB09496Mesalazine may decrease the excretion rate of Octinoxate which could result in a higher serum level.
DB09502Mesalazine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.
DB09546Mesalazine may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.
DB09570Mesalazine may decrease the excretion rate of Ixazomib which could result in a higher serum level.
DB11077Mesalazine may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.
DB11090Mesalazine may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.
DB11098Mesalazine may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.
DB11102Mesalazine may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.
DB11114Mesalazine may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.
DB11127Mesalazine may decrease the excretion rate of Selenious acid which could result in a higher serum level.
DB11130Mesalazine may decrease the excretion rate of Opium which could result in a higher serum level.
DB11135Mesalazine may decrease the excretion rate of Selenium which could result in a higher serum level.
DB11136Mesalazine may decrease the excretion rate of Chromium which could result in a higher serum level.
DB11145Mesalazine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.
DB11156Mesalazine may decrease the excretion rate of Pyrantel which could result in a higher serum level.
DB11164Mesalazine may decrease the excretion rate of Bicisate which could result in a higher serum level.
DB11251Mesalazine may decrease the excretion rate of Tocopherol which could result in a higher serum level.
DB11278Mesalazine may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.
DB11328Mesalazine may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.
DB11338Mesalazine may decrease the excretion rate of Clove oil which could result in a higher serum level.
DB11358Mesalazine may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.
DB11364Mesalazine may decrease the excretion rate of Pidotimod which could result in a higher serum level.
DB11367Mesalazine may decrease the excretion rate of Cefroxadine which could result in a higher serum level.
DB11560Mesalazine may decrease the excretion rate of Lesinurad which could result in a higher serum level.
DB11577Mesalazine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.
DB11587Mesalazine may decrease the excretion rate of Etafedrine which could result in a higher serum level.
DB11691Mesalazine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
DB11699Mesalazine may decrease the excretion rate of Tropisetron which could result in a higher serum level.
DB11817Mesalazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
DB11901Mesalazine may decrease the excretion rate of Apalutamide which could result in a higher serum level.
DB11915Mesalazine may decrease the excretion rate of Valbenazine which could result in a higher serum level.
DB11943Mesalazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
DB11989Mesalazine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
DB12007Mesalazine may decrease the excretion rate of Isoflavone which could result in a higher serum level.
DB12107Mesalazine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.
DB12151Mesalazine may decrease the excretion rate of Brincidofovir which could result in a higher serum level.
DB12161Mesalazine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
DB12278Mesalazine may decrease the excretion rate of Propiverine which could result in a higher serum level.
DB12783Mesalazine may decrease the excretion rate of Benserazide which could result in a higher serum level.
DB13025Mesalazine may decrease the excretion rate of Tiapride which could result in a higher serum level.
DB13139Mesalazine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.
DB13156Mesalazine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.
DB13178Mesalazine may decrease the excretion rate of Inositol which could result in a higher serum level.
DB13185Mesalazine may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.
DB13191Mesalazine may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.
DB13269Mesalazine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.
DB13293Mesalazine may decrease the excretion rate of Ipecac which could result in a higher serum level.
DB13873Mesalazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.
DB13884Mesalazine may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
DB13909Mesalazine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.
DB13943Mesalazine may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.
DB13944Mesalazine may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.
DB13952Mesalazine may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.
DB13954Mesalazine may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.
DB13955Mesalazine may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.
DB13956Mesalazine may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.
DB13967Mesalazine may decrease the excretion rate of Patent Blue which could result in a higher serum level.
DB14007Mesalazine may decrease the excretion rate of Pentetic acid which could result in a higher serum level.
DB14498Mesalazine may decrease the excretion rate of Potassium acetate which could result in a higher serum level.
DB14499Mesalazine may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.
DB14526Mesalazine may decrease the excretion rate of Chromic citrate which could result in a higher serum level.
DB14527Mesalazine may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.
DB14528Mesalazine may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.
DB14529Mesalazine may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.
DB14530Mesalazine may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.
DB06815Mesalazine may decrease the excretion rate of Pyrithione which could result in a higher serum level.
DB11121Mesalazine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.
DB11085Mesalazine may decrease the excretion rate of Resorcinol which could result in a higher serum level.
DB00270Mesalazine may decrease the excretion rate of Isradipine which could result in a higher serum level.
DB00401Mesalazine may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
DB00555Mesalazine may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
DB01115Mesalazine may decrease the excretion rate of Nifedipine which could result in a higher serum level.
DB04920Mesalazine may decrease the excretion rate of Clevidipine which could result in a higher serum level.
DB09089Mesalazine may decrease the excretion rate of Trimebutine which could result in a higher serum level.
DB15593Mesalazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.
DB00321Mesalazine may decrease the excretion rate of Amitriptyline which could result in a higher serum level.
DB00458Mesalazine may decrease the excretion rate of Imipramine which could result in a higher serum level.
DB00813Mesalazine may decrease the excretion rate of Fentanyl which could result in a higher serum level.
DB01151Mesalazine may decrease the excretion rate of Desipramine which could result in a higher serum level.
DB01242Mesalazine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
DB08996Mesalazine may decrease the excretion rate of Dimetacrine which could result in a higher serum level.
DB00318Mesalazine may decrease the excretion rate of Codeine which could result in a higher serum level.
DB00454Mesalazine may decrease the excretion rate of Meperidine which could result in a higher serum level.
DB00879Mesalazine may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
DB13987Mesalazine may decrease the excretion rate of Strontium chloride which could result in a higher serum level.
DB01345Mesalazine may decrease the excretion rate of Potassium cation which could result in a higher serum level.
DB04890Mesalazine may decrease the excretion rate of Bepotastine which could result in a higher serum level.
DB00982Mesalazine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
DB04930Mesalazine may decrease the excretion rate of Permethrin which could result in a higher serum level.
DB00479Mesalazine may decrease the excretion rate of Amikacin which could result in a higher serum level.
DB00684Mesalazine may decrease the excretion rate of Tobramycin which could result in a higher serum level.
DB00798Mesalazine may decrease the excretion rate of Gentamicin which could result in a higher serum level.
DB00955Mesalazine may decrease the excretion rate of Netilmicin which could result in a higher serum level.
DB01082Mesalazine may decrease the excretion rate of Streptomycin which could result in a higher serum level.
DB01172Mesalazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.
DB03615Mesalazine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.
DB04729Mesalazine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.
DB06696Mesalazine may decrease the excretion rate of Arbekacin which could result in a higher serum level.
DB12604Mesalazine may decrease the excretion rate of Sisomicin which could result in a higher serum level.
DB13540Mesalazine may decrease the excretion rate of Isepamicin which could result in a higher serum level.
DB00314Mesalazine may decrease the excretion rate of Capreomycin which could result in a higher serum level.
DB00515Mesalazine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
DB00564Mesalazine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
DB00908Mesalazine may decrease the excretion rate of Quinidine which could result in a higher serum level.
DB01035Mesalazine may decrease the excretion rate of Procainamide which could result in a higher serum level.
DB12615Mesalazine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
DB00552Mesalazine may decrease the excretion rate of Pentostatin which could result in a higher serum level.
DB13145Mesalazine may decrease the excretion rate of Nedaplatin which could result in a higher serum level.
DB00803Mesalazine may decrease the excretion rate of Colistin which could result in a higher serum level.
DB09087Potassium alum may increase the hyperkalemic activities of Mesalazine.
DB09414Dipotassium phosphate may increase the hyperkalemic activities of Mesalazine.
DB09483Potassium lactate may increase the hyperkalemic activities of Mesalazine.
DB11107Potassium bitartrate may increase the hyperkalemic activities of Mesalazine.
DB11153Potassium hydroxide may increase the hyperkalemic activities of Mesalazine.
DB13620Potassium gluconate may increase the hyperkalemic activities of Mesalazine.
DB13735Potassium guaiacolsulfonate may increase the hyperkalemic activities of Mesalazine.
DB13831Potassium permanganate may increase the hyperkalemic activities of Mesalazine.
DB13977Potassium carbonate may increase the hyperkalemic activities of Mesalazine.
DB14492Potassium triiodide may increase the hyperkalemic activities of Mesalazine.
DB14500Potassium may increase the hyperkalemic activities of Mesalazine.
DB06715Potassium Iodide may increase the hyperkalemic activities of Mesalazine.
DB00252The serum concentration of Phenytoin can be increased when it is combined with Mesalazine.
DB00581Lactulose can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB13074The therapeutic efficacy of Macimorelin can be decreased when used in combination with Mesalazine.
DB00024The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Mesalazine.
DB00451The therapeutic efficacy of Levothyroxine can be increased when used in combination with Mesalazine.
DB01583The therapeutic efficacy of Liotrix can be increased when used in combination with Mesalazine.
DB03604The therapeutic efficacy of Tiratricol can be increased when used in combination with Mesalazine.
DB09100The therapeutic efficacy of Thyroid, porcine can be increased when used in combination with Mesalazine.
DB11823The risk or severity of hypertension can be increased when Esketamine is combined with Mesalazine.
DB00781The risk or severity of adverse effects can be increased when Mesalazine is combined with Polymyxin B.
DB14754The risk or severity of hypertension can be increased when Solriamfetol is combined with Mesalazine.
DB00316The risk or severity of adverse effects can be increased when Acetaminophen is combined with Mesalazine.
DB09288The risk or severity of adverse effects can be increased when Propacetamol is combined with Mesalazine.
DB13946Testosterone undecanoate may increase the hypertensive activities of Mesalazine.
DB00181Mesalazine may decrease the excretion rate of Baclofen which could result in a higher serum level.
DB00898The risk or severity of gastrointestinal irritation can be increased when Ethanol is combined with Mesalazine.
DB00495The risk or severity of bleeding can be increased when Zidovudine is combined with Mesalazine.
DB00063The risk or severity of bleeding can be increased when Mesalazine is combined with Eptifibatide.
DB00208The risk or severity of bleeding can be increased when Mesalazine is combined with Ticlopidine.
DB00758The risk or severity of bleeding can be increased when Mesalazine is combined with Clopidogrel.
DB00775The risk or severity of bleeding can be increased when Mesalazine is combined with Tirofiban.
DB00806The risk or severity of bleeding can be increased when Mesalazine is combined with Pentoxifylline.
DB01138The risk or severity of bleeding can be increased when Mesalazine is combined with Sulfinpyrazone.
DB01166The risk or severity of bleeding can be increased when Mesalazine is combined with Cilostazol.
DB01207The risk or severity of bleeding can be increased when Mesalazine is combined with Ridogrel.
DB01236The risk or severity of bleeding can be increased when Mesalazine is combined with Sevoflurane.
DB02709The risk or severity of bleeding can be increased when Mesalazine is combined with Resveratrol.
DB04905The risk or severity of bleeding can be increased when Mesalazine is combined with Tesmilifene.
DB05266The risk or severity of bleeding can be increased when Mesalazine is combined with Ibudilast.
DB05767The risk or severity of bleeding can be increased when Mesalazine is combined with Andrographolide.
DB06081The risk or severity of bleeding can be increased when Mesalazine is combined with Caplacizumab.
DB07615The risk or severity of bleeding can be increased when Mesalazine is combined with Tranilast.
DB08887The risk or severity of bleeding can be increased when Mesalazine is combined with Icosapent ethyl.
DB09283The risk or severity of bleeding can be increased when Mesalazine is combined with Trapidil.
DB12092The risk or severity of bleeding can be increased when Mesalazine is combined with Naftopidil.
DB12163The risk or severity of bleeding can be increased when Mesalazine is combined with Sarpogrelate.
DB12321The risk or severity of bleeding can be increased when Mesalazine is combined with Ifetroban.
DB12465The risk or severity of bleeding can be increased when Mesalazine is combined with Ketanserin.
DB12749The risk or severity of bleeding can be increased when Mesalazine is combined with Butylphthalide.
DB12771The risk or severity of bleeding can be increased when Mesalazine is combined with Hydroxytyrosol.
DB13036The risk or severity of bleeding can be increased when Mesalazine is combined with Ramatroban.
DB13327The risk or severity of bleeding can be increased when Mesalazine is combined with Picotamide.
DB13367The risk or severity of bleeding can be increased when Mesalazine is combined with Cloricromen.
DB13400The risk or severity of bleeding can be increased when Mesalazine is combined with Linsidomine.
DB13510The risk or severity of bleeding can be increased when Mesalazine is combined with Buflomedil.
DB13929The risk or severity of bleeding can be increased when Mesalazine is combined with Relcovaptan.
DB00261The risk or severity of bleeding can be increased when Anagrelide is combined with Mesalazine.
DB00695The risk or severity of adverse effects can be increased when Mesalazine is combined with Furosemide.
DB01104The risk or severity of bleeding can be increased when Sertraline is combined with Mesalazine.
DB01320The protein binding of Fosphenytoin can be decreased when combined with Mesalazine.
DB00869The risk or severity of metabolic acidosis can be increased when Dorzolamide is combined with Mesalazine.
DB00994The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Neomycin.
DB00465The risk or severity of adverse effects can be increased when Ketorolac is combined with Mesalazine.